Document:

Exhibit 4.1

 

REGISTRATION RIGHTS AGREEMENT

 

THIS REGISTRATION RIGHTS
AGREEMENT (this “Agreement”), dated as of December 7, 2022, by and between SONO GROUP N.V., a Dutch
public limited liability company (the “Company”), and YA II PN, Ltd., a Cayman Islands exempt limited partnership
(the “Investor”).

 

WITNESSETH

 

WHEREAS:

 

A.       In
connection with the Securities Purchase Agreement of even date herewith by and between the parties hereto (the “Securities Purchase
Agreement”), the Company has agreed, upon the terms and subject to the conditions of the Securities Purchase Agreement, to issue
and sell to the Investor up to $31,100,000 of convertible debentures (the “Convertible Debentures”), which shall be
convertible into ordinary shares of the Company, nominal value €0.06 (the “Ordinary Shares”) (as converted, the
 “Conversion Shares”). Capitalized terms not defined herein shall have the meaning ascribed to them in the Securities
Purchase Agreement.

 

B.       To
induce the Investor to execute and deliver the Securities Purchase Agreement, the Company has agreed to provide certain registration rights
under the Securities Act of 1933, as amended, and the rules and regulations thereunder, or any similar successor statute (collectively,
the “Securities Act”), and applicable state securities laws and other rights as provided for herein.

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and other good and valuable consideration, the receipt and sufficiency
of which are hereby acknowledged, the Company and the Investor hereby agree as follows:

 

1.             DEFINITIONS.

 

As used in this Agreement,
the following terms shall have the following meanings:

 

(a)              
“Effectiveness Deadline” means, with respect to a Registration Statement filed hereunder, the 60th calendar
day following the filing date thereof, provided, however, in the event the Company is notified by the U.S. Securities and Exchange Commission
(“SEC”) that one of the Registration Statements, as defined below, will not be reviewed or is no longer subject to
further review and comments, the Effectiveness Deadline as to such Registration Statement shall be the fifth business day following the
date on which the Company is so notified if such date precedes the date required above.

 

(b)              
“Exchange Act” means the Securities Exchange Act of 1934, as amended, and the rules and regulations promulgated
thereunder.

 

     

     

    

 

(c)              
 “Filing Deadline” means, with respect to a Registration Statement required hereunder, the 21st calendar
day following the date hereof.

 

(d)              
“Person” means a corporation, a limited liability company, an association, a partnership, an organization, a
business, an individual, a governmental or political subdivision thereof or a governmental agency.

 

(e)              
“Prospectus” means the prospectus included in a Registration Statement (including, without limitation, a prospectus
that includes any information previously omitted from a prospectus filed as part of an effective registration statement in reliance upon
Rule 430A promulgated under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of
the offering of any portion of the Registrable Securities covered by a Registration Statement, and all other amendments and supplements
to the Prospectus, including post-effective amendments, and all material incorporated by reference or deemed to be incorporated by
reference in such Prospectus.

 

(f)               
“Registrable Securities” means all of (i) the Ordinary Shares issuable upon conversion of the Convertible Debentures,
(ii) the additional shares issuable in connection with any anti-dilution provisions of the Convertible Debentures (without giving effect
to any limitations on exercise set forth in the Convertible Debentures) and (iii) any Ordinary Shares issued or issuable with respect
to any shares described in subsections (i) and (ii) above by way of any stock split, stock dividend or other distribution, recapitalization
or similar event or otherwise (in each case without giving effect to any limitations on exercise set forth in the Convertible Debentures).
 “Registration Statement” means the registration statements of the Company required to be filed hereunder (including
any additional registration statements contemplated by Section 2(c) hereunder), including in each case the Prospectus, amendments and
supplements to such registration statement or Prospectus, including post-effective amendments, all exhibits thereto, and all material
incorporated by reference or deemed to be incorporated by reference in such registration statement.

 

(g)              
“Required Registration Amount” means (i) with respect to the initial Registration Statement, at least 30,000,000
Ordinary Shares issuable upon conversion of all Convertible Debentures then outstanding and (ii) to the extent that additional Registrable
Securities remain outstanding after substantially all shares under the initial Registration Statement have been sold, the Company shall
be required to file additional Registration Statements for such Registrable Securities as soon as permissible under SEC rules and regulations,
in each case subject to any cutback set forth in Section 2(d).

 

(h)              
“Rule 144” means Rule 144 under the Securities Act or any successor rule thereto.

 

(i)                “Rule
415” means Rule 415 promulgated by the SEC pursuant to the Securities Act, as such Rule may be amended from time to time, or
any similar rule or regulation hereafter adopted by the SEC having substantially the same purpose and effect as such Rule.

 

(j)                “SEC” means the Securities and Exchange Commission or any other federal agency administering the Securities
Act and the Exchange Act at the time.

 

(k)              
 “Securities Act” shall have the meaning set forth in the Recitals above.

 

    2

     

    

 

2.             REGISTRATION.

 

(a)              
The Company’s registration obligations set forth in this Section 2 including its obligations to file Registration Statements,
obtain effectiveness of Registration Statements, and maintain the continuous effectiveness of any Registration Statement that has been
declared effective shall begin on the date hereof and continue until all the Registrable Securities have been sold or may permanently
be sold without any restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter
to such effect, addressed and acceptable to the Company’s transfer agent and the Investor (the “Registration Period”).

 

(b)              
Subject to the terms and conditions of this Agreement, the Company shall (i) on or prior to the Filing Deadline, prepare and file
with the SEC an initial Registration Statement on Form F-3 or Form F-1 or any successor forms thereto covering the resale by the Investor
of Registrable Securities and (ii) as soon as permissible under SEC rules and regulations, in the case of any cutback set forth in Section
2(d), file additional Registration Statements for such Registrable Securities. Each Registration Statement prepared pursuant hereto shall
register for resale at least the number of Ordinary Shares equal to the Required Registration Amount as of date the Registration Statement
is initially filed with the SEC. Each Registration Statement shall contain “Selling Stockholders” and “Plan
of Distribution” sections. The Company shall use its best efforts to have each Registration Statement declared effective by
the SEC as soon as practicable, but in no event later than the Effectiveness Deadline. By 9:30 am on the business day following the date
of effectiveness, the Company shall file with the SEC in accordance with Rule 424 under the 1933 Act the final Prospectus to be used in
connection with sales pursuant to such Registration Statement. Prior to the filing of the Registration Statement with the SEC, the Company
shall furnish a draft of the Registration Statement to the Investor for their review and comment. The Investor shall furnish comments
on the Registration Statement to the Company within 24 hours of the receipt thereof from the Company.

 

(c)               During
the Registration Period, the Company shall (i) promptly prepare and file with the SEC such amendments (including post-effective
amendments) and supplements to a Registration Statement and the Prospectus used in connection with a Registration Statement, which
Prospectus is to be filed pursuant to Rule 424 promulgated under the Securities Act, as may be necessary to keep such Registration
Statement effective at all times during the Registration Period, (ii) prepare and file with the SEC additional Registration
Statements in order to register for resale under the Securities Act all of the Registrable Securities; (iii) cause the related
Prospectus to be amended or supplemented by any required Prospectus supplement (subject to the terms of this Agreement), and as so
supplemented or amended to be filed pursuant to Rule 424; (iv) respond as promptly as reasonably possible to any comments received
from the SEC with respect to a Registration Statement or any amendment thereto and as promptly as reasonably possible provide the
Investor true and complete copies of all correspondence from and to the SEC relating to a Registration Statement (provided that the
Company may excise any information contained therein which would constitute material non-public information unless the Investor has
executed a confidentiality agreement with the Company); and (v) comply with the provisions of the Securities Act with respect to the
disposition of all Registrable Securities of the Company covered by such Registration Statement until such time as all of such
Registrable Securities shall have been disposed of in accordance with the intended methods of disposition by the seller or sellers
thereof as set forth in such Registration Statement. In the case of amendments and supplements to a Registration Statement which are
required to be filed pursuant to this Agreement (including pursuant to this Section 2(c)) by reason of the Company’s filing a
report on Form 20-F or Form 6-K or any analogous report under the Exchange Act, the Company shall incorporate such report by
reference into the Registration Statement, if applicable, or shall file such amendments or supplements with the SEC on the same day
on which the Exchange Act report is filed which created the requirement for the Company to amend or supplement the Registration
Statement.

 

    3

     

    

 

(d)              
Reduction of Registrable Securities Included in a Registration Statement. Notwithstanding anything contained herein, in
the event that the SEC requires the Company to reduce the number of Registrable Securities to be included in a Registration Statement
in order to allow the Company to rely on Rule 415 with respect to a Registration Statement or otherwise comply with the SEC’s rules
and regulations, then the Company shall be obligated to include in such Registration Statement (which may be a subsequent Registration
Statement if the Company needs to withdraw a Registration Statement and refile a new Registration Statement in order to rely on Rule 415)
only such limited portion of the Registrable Securities as the SEC shall permit. Any Registrable Securities that are excluded in accordance
with the foregoing terms are hereinafter referred to as “Cut Back Securities.” To the extent Cut Back Securities exist,
promptly following such time as may be permitted by the SEC, the Company shall be required to file a Registration Statement covering the
resale of the Cut Back Securities (subject also to the terms of this Section) and shall use best efforts to cause such Registration Statement
to be declared effective as promptly as practicable thereafter.

 

(e)              
Failure to File or Obtain Effectiveness of the Registration Statement or Remain Current. If: (i) a Registration Statement
is not filed on or prior to the end of the Filing Deadline, or (ii) a Registration Statement is not declared effective on or prior to
Effectiveness Deadline or the Company fails to file with the SEC a request for acceleration in accordance with Rule 461 promulgated under
the Securities Act, within five business days of the date that the Company is notified (orally or in writing, whichever is earlier) by
the SEC that a Registration Statement will not be “reviewed,” or not subject to further review, or (iii) after a Registration
Statement has been declared effective by the SEC, sales cannot be made pursuant to such Registration Statement for any reason (including,
without limitation, by reason of a stop order or the Company’s failure to update such Registration Statement but excluding any Allowed
Delay as set forth in Section 2(g) hereof or the inability of the Investor to sell the Registrable Securities covered thereby due to market
conditions), or (iv) after the date that is six months from the date hereof, the Company does not have available adequate current public
information as set forth in Rule 144(c) (any such failure or breach being referred to as an “Event”), then in addition
to any other rights the holders of the Convertible Debentures may have hereunder or under applicable law, the Company shall be in breach
of the term and conditions of this Agreement and such Event shall be deemed an event of default under the Convertible Debentures for so
long as such Event remains uncured.

 

(f)                Piggy-Back
Registrations. If at any time there is not an effective Registration Statement covering all of the Registrable Securities and
the Company proposes to register the offer and sale of any Ordinary Shares under the Securities Act (other than a registration (i)
pursuant to a Registration Statement on Form S-8 (or other registration solely relating to an offering or sale to employees or
directors of the Company pursuant to any employee stock plan or other employee benefit arrangement), (ii) pursuant to a Registration
Statement on Form S-4 (or similar form that relates to a transaction subject to Rule 145 under the Securities Act or any successor
rule thereto), or (iii) in connection with any dividend or distribution reinvestment or similar plan), whether for its own account
or for the account of one or more stockholders of the Company and the form of Registration Statement to be used may be used for any
registration of Registrable Securities, the Company shall give prompt written notice (in any event no later than five days prior to
the filing of such Registration Statement) to the holders of Registrable Securities of its intention to effect such a registration
and, shall include in such registration all Registrable Securities with respect to which the Company has received written requests
for inclusion from the holders of Registrable Securities; provided, however, that, the Company shall not be required
to register any Registrable Securities pursuant to this Section 2(f) that have been sold or may permanently be sold without any
restrictions pursuant to Rule 144, as determined by the counsel to the Company pursuant to a written opinion letter to such effect,
addressed and acceptable to the Company’s transfer agent.

 

    4

     

    

 

(g)              
For not more than twenty (20) consecutive days or for a total of not more than thirty (30) days in any twelve (12) month
period, the Company may suspend the use of any Prospectus included in any Registration Statement contemplated by this Section in the event
that the Company determines in good faith that such suspension is necessary to (A) delay the disclosure of material nonpublic information
concerning the Company, the disclosure of which at the time is not, in the good faith opinion of the Company, in the best interests of
the Company or (B) amend or supplement the affected Registration Statement or the related Prospectus so that such Registration Statement
or Prospectus shall not include an untrue statement of a material fact or omit to state a material fact required to be stated therein
or necessary to make the statements therein, in the case of the Prospectus in light of the circumstances under which they were made, not
misleading (an “Allowed Delay”); provided, that the Company shall promptly (a) notify the Investor in writing
of the commencement (and the termination) of an Allowed Delay, but shall not (without the prior written consent of the Investor) disclose
to the Investor any material nonpublic information giving rise to an Allowed Delay, (b) advise the Investor in writing to cease all
sales under such Registration Statement until the end of the Allowed Delay, and (c) use commercially reasonable efforts to terminate
an Allowed Delay as promptly as practicable.

 

3.             RELATED
OBLIGATIONS.

 

(a)               The
Company shall, not less than three business days prior to the filing of each Registration Statement and not less than one business
day prior to the filing of any related amendments and supplements to all Registration Statements (except for annual reports on Form
20-F, supplements and amendments to update the Registration Statement solely for information reflected in the Company’s annual
reports on Form 20-Fand interim financial reports and current reports on Form 6-K), furnish to the Investor electronic copies of all
such documents proposed to be filed, which documents (other than those incorporated or deemed to be incorporated by reference) will
be subject to the reasonable and prompt review by the Investor. The Company shall not file a Registration Statement or any such
Prospectus or any amendments or supplements thereto to which the Investor shall reasonably object in good faith; provided
that, the Company is notified of such objection in writing no later than two (2) business day after the Investor has been so
furnished copies of a Registration Statement.

 

    5

     

    

 

(b)              
The Company shall furnish to the Investor, without charge, (i) at least one electronic copy of the Registration Statement as declared
effective by the SEC and any amendment(s) thereto, including financial statements and schedules, all documents incorporated therein by
reference, all exhibits and the preliminary prospectus, (ii) an electronic copy of the final prospectus included in such Registration
Statement and all amendments and supplements thereto , and (iii) such other documents in electronic form, which are not publicly available
through EDGAR, as the Investor may reasonably request from time to time in order to facilitate the disposition of the Registrable Securities
owned by the Investor.

 

(c)              
The Company shall use its best efforts to (i) register and qualify the Registrable Securities covered by a Registration Statement
under such other securities or “blue sky” laws of such jurisdictions in the United States as the Investor reasonably requests,
(ii) prepare and file in those jurisdictions, such amendments (including post-effective amendments) and supplements to such registrations
and qualifications as may be necessary to maintain the effectiveness thereof during the Registration Period, (iii) take such other actions
as may be necessary to maintain such registrations and qualifications in effect at all times during the Registration Period, and (iv)
take all other actions reasonably necessary or advisable to qualify the Registrable Securities for sale in such jurisdictions; provided,
however, that the Company shall not be required in connection therewith or as a condition thereto to (w) make any change to its articles
of association, (x) qualify to do business in any jurisdiction where it would not otherwise be required to qualify but for this Section
3(c), (y) subject itself to general taxation in any such jurisdiction, or (z) file a general consent to service of process in any such
jurisdiction. The Company shall promptly notify the Investor of the receipt by the Company of any notification with respect to the suspension
of the registration or qualification of any of the Registrable Securities for sale under the securities or “blue sky” laws
of any jurisdiction in the United States or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.
As promptly as practicable after becoming aware of such event or development, the Company shall notify the Investor of the happening of
any event as a result of which the Prospectus included in a Registration Statement, as then in effect, includes an untrue statement of
a material fact or omission to state a material fact required to be stated therein or necessary to make the statements therein, in light
of the circumstances under which they were made, not misleading (provided that in no event shall such notice contain any material, nonpublic
information), and promptly prepare a supplement or amendment to such Registration Statement to correct such untrue statement or omission,
and deliver an electronic copy of such supplement or amendment to the Investor. The Company shall also promptly notify the Investor in
writing (i) when a Prospectus or any Prospectus supplement or post-effective amendment has been filed, and when a Registration Statement
or any post-effective amendment has become effective (notification of such effectiveness shall be delivered to the Investor by email on
the same day of such effectiveness), (ii) of any request by the SEC for amendments or supplements to a Registration Statement or related
prospectus or related information, and (iii) of the Company’s reasonable determination that a post-effective amendment to a
Registration Statement would be appropriate.

 

    6

     

    

 

(d)              
 The Company shall use its best efforts to prevent the issuance of any stop order or other suspension of effectiveness of a Registration
Statement, or the suspension of the qualification of any of the Registrable Securities for sale in any jurisdiction within the United
States of America and, if such an order or suspension is issued, to obtain the withdrawal of such order or suspension at the earliest
possible moment and to notify the Investor who holds Registrable Securities being sold of the issuance of such order and the resolution
thereof or its receipt of actual notice of the initiation or threat of any proceeding for such purpose.

 

(e)              
The Company shall hold in confidence and not make any disclosure of information concerning the Investor provided to the Company
unless (i) disclosure of such information is necessary to comply with federal or state securities laws, (ii) the disclosure of such information
is necessary to avoid or correct a misstatement or omission in any Registration Statement, (iii) the release of such information is ordered
pursuant to a subpoena or other order from a court or governmental body of competent jurisdiction, (iv) such information is independently
developed by an employee of the Company who has not had access to the information received from the Investor; or (v) such information,
at the time of disclosure by the Investor or thereafter, is obtained by the Company from a third party that has the right to share such
information or (iv) such information has been made generally available to the public other than by disclosure in violation of this Agreement
or any other agreement. The Company agrees that it shall, upon learning that disclosure of such information concerning the Investor is
sought in or by a court or governmental body of competent jurisdiction or through other means, give prompt written notice to the Investor
and allow the Investor, at the Investor’s expense, to undertake appropriate action to prevent disclosure of, or to obtain a protective
order for, such information.

 

(f)               
The Company shall use its best efforts to cause all the Registrable Securities to be listed on each securities exchange on which
the Ordinary Shares are then listed. The Company shall pay all fees and expenses in connection with satisfying its obligation under this
Section 3(g).

 

(g)              
The Company shall cooperate with the Investor to facilitate the timely preparation and delivery of certificates representing the
Registrable Securities to be sold pursuant to such Registration Statement or pursuant to Rule 144 free of any restrictive legends and
representing such number of Ordinary Shares and registered in such names as the Investor may reasonably request a reasonable period of
time prior to sales of Registrable Securities pursuant to such Registration Statement or Rule; provided, that the Company may satisfy
its obligations hereunder without issuing physical stock certificates through the use of The Depository Trust Company's Direct Registration
System.

 

(h)              
The Company shall use its best efforts to cause the Registrable Securities covered by the applicable Registration Statement to
be registered with or approved by such other governmental agencies or authorities as may be necessary to consummate the disposition of
such Registrable Securities.

 

(i)                
The Company shall otherwise use its best efforts to comply with all applicable rules and regulations of the SEC in connection with
any registration hereunder.

 

    7

     

    

 

(j)                
 Within two business days after a Registration Statement which covers Registrable Securities is declared effective by the SEC,
the Company shall deliver, and shall cause legal counsel for the Company to deliver, to the transfer agent for such Registrable Securities
(with copies to the Investor whose Registrable Securities are included in such Registration Statement) confirmation that such Registration
Statement has been declared effective by the SEC.

 

(k)              
The Company shall take all other reasonable actions necessary to expedite and facilitate disposition by the Investor of Registrable
Securities pursuant to a Registration Statement.

 

4.             OBLIGATIONS
OF THE INVESTOR.

 

(a)              
The Investor agrees that, upon receipt of any notice from the Company of the happening of any event of the kind described in Section
3(d) the Investor will immediately discontinue disposition of Registrable Securities pursuant to any Registration Statement covering such
Registrable Securities until the Investor’s receipt of the copies of the supplemented or amended prospectus contemplated by Section
3(d) or receipt of notice that no supplement or amendment is required. Notwithstanding anything to the contrary, subject to compliance
with the securities laws, the Company shall cause its transfer agent to deliver unlegended certificates for Ordinary Shares to a transferee
of the Investor in accordance with the terms of the Securities Purchase Agreement in connection with any sale of Registrable Securities
with respect to which the Investor has entered into a contract for sale prior to the Investor’s receipt of a notice from the Company
of the happening of any event of the kind described in Section 3(d) and for which the Investor has not yet settled.

 

(b)              
The Investor covenants and agrees that it will comply with the prospectus delivery requirements of the Securities Act as applicable
to it or an exemption therefrom in connection with sales of Registrable Securities pursuant to the Registration Statement.

 

5.             EXPENSES
OF REGISTRATION.

 

All expenses incurred by the
Company in complying with its obligations pursuant to this Agreement and in connection with the registration, and related obligations
pursuant to Sections 2 and 3 of this Agreement, of Registrable Securities shall be paid by the Company, including, without limitation,
all registration, listing and qualification fees, printers, fees and expenses of the Company's counsel and accountants. For the avoidance
of doubt, the Company shall not bear legal fees of Investor’s counsel associated with the review of the Registration Statement,
any comment letters issued by the SEC relating to such Registration Statement, this Agreement and other agreements and documents reviewed
in connection with the transactions contemplated by this Agreement).

 

    8

     

    

 

6.             INDEMNIFICATION.

 

With respect to Registrable
Securities which are included in a Registration Statement under this Agreement:

 

(a)                To the fullest extent permitted by law, the Company will, and hereby does, indemnify, hold harmless and defend the Investor, the
directors, officers, partners, employees, agents, representatives of, and each Person, if any, who controls the Investor within the meaning
of the Securities Act or the Exchange Act (each, an “Indemnified Person”), against any losses, claims, damages, liabilities,
judgments, fines, penalties, charges, costs, reasonable attorneys’ fees, amounts paid in settlement or expenses, joint or several
(collectively, “Claims”) incurred in investigating, preparing or defending any action, claim, suit, inquiry, proceeding,
investigation or appeal taken from the foregoing by or before any court or governmental, administrative or other regulatory agency, body
or the SEC, whether pending or threatened, whether or not an indemnified party is or may be a party thereto (“Indemnified Damages”),
to which any of them may become subject insofar as such Claims (or actions or proceedings, whether commenced or threatened, in respect
thereof) arise out of or are based upon: (i) any untrue statement or alleged untrue statement of a material fact in a Registration Statement
or any post-effective amendment thereto or in any filing made in connection with the qualification of the offering under the securities
or other “blue sky” laws of any jurisdiction in which Registrable Securities are offered (“Blue Sky Filing”),
or the omission or alleged omission to state a material fact required to be stated therein or necessary to make the statements therein
not misleading; (ii) any untrue statement or alleged untrue statement of a material fact contained in any final prospectus (as amended
or supplemented, if the Company files any amendment thereof or supplement thereto with the SEC) or the omission or alleged omission to
state therein any material fact necessary to make the statements made therein, in light of the circumstances under which the statements
therein were made, not misleading; or (iii) any violation or alleged violation by the Company of the Securities Act, the Exchange Act,
any other law, including, without limitation, any state securities law, or any rule or regulation there under relating to the offer or
sale of the Registrable Securities pursuant to a Registration Statement (the matters in the foregoing clauses (i) through (iii) being,
collectively, “Violations”). The Company shall reimburse the Investor and each such controlling person promptly as
such expenses are incurred and are due and payable, for any reasonable legal fees or disbursements or other reasonable expenses incurred
by them in connection with investigating or defending any such Claim. Notwithstanding anything to the contrary contained herein, the
indemnification agreement contained in this Section 6(a): (w) shall not apply to a Claim by an Indemnified Person arising out of or based
upon a Violation which occurs in reliance upon and in conformity with information furnished in writing to the Company by such Indemnified
Person expressly for use in connection with the preparation of the Registration Statement or any such amendment thereof or supplement
thereto; (x) shall not be available to the extent such Claim is based on a failure of the Investor to deliver or to cause to be delivered
the prospectus made available by the Company, if such prospectus was timely made available by the Company pursuant to Section 3(b) or
3(d); (y) shall not apply to amounts paid in settlement of any Claim if such settlement is effected without the prior written consent
of the Company, which consent shall not be unreasonably withheld; and (z) shall not apply to the extent that any Claim by an Indemnified
Person is finally determined by a court or arbitral tribunal to have resulted from the willful misconduct or gross negligence of the
Investor or any other Indemnified Person, and any expenses incurred in connection therewith that were previously reimbursed to the Investor
or any other Indemnified Person by the Company will be repaid to the Company by the Investor and such other Indemnified Person. Such
indemnity shall remain in full force and effect regardless of any investigation made by or on behalf of the Indemnified Person.

 

    9

     

    

 

(b)              
 In connection with a Registration Statement, the Investor agrees to severally and not jointly indemnify, hold harmless and defend,
to the same extent and in the same manner as is set forth in Section 6(a), the Company, each of its directors, each of its officers, employees,
representatives, or agents and each Person, if any, who controls the Company within the meaning of the Securities Act or the Exchange
Act (each an “Indemnified Party”), against any Claim or Indemnified Damages to which any of them may become subject,
under the Securities Act, the Exchange Act or otherwise, insofar as such Claim or Indemnified Damages arise out of or is based upon any
Violation, in each case to the extent, and only to the extent, that such Violation occurs in reliance upon and in conformity with information
furnished to the Company by the Investor for use in connection with such Registration Statement; and, subject to Section 6(d), the Investor
will reimburse any legal or other expenses reasonably incurred by them in connection with investigating or defending any such Claim, whether
pending or threatened; provided, however, that the indemnity agreement contained in this Section 6(b) and the agreement with respect to
contribution contained in Section 7 shall not apply to amounts paid in settlement of any Claim if such settlement is effected without
the prior written consent of the Investor, which consent shall not be unreasonably withheld; provided, further, however, that the Investor
shall be liable under this Section 6(b) for only that amount of a Claim or Indemnified Damages as does not exceed the net proceeds to
the Investor as a result of the sale of Registrable Securities pursuant to such Registration Statement. Such indemnity shall remain in
full force and effect regardless of any investigation made by or on behalf of such Indemnified Party. Notwithstanding anything to the
contrary contained herein, the indemnification agreement contained in this Section 6(b) with respect to any prospectus shall not inure
to the benefit of any Indemnified Party if the untrue statement or omission of material fact contained in the prospectus was corrected
and such new prospectus was delivered to the Investor prior to the Investor’s use of the prospectus to which the Claim relates.

 

(c)               Promptly
after receipt by an Indemnified Person or Indemnified Party under this Section 6 of notice of the commencement of any action or
proceeding (including any governmental action or proceeding) involving a Claim, such Indemnified Person or Indemnified Party shall,
if a Claim in respect thereof is to be made against any indemnifying party under this Section 6, deliver to the indemnifying party a
written notice of the commencement thereof, and the indemnifying party shall have the right to participate in, and, to the extent
the indemnifying party so desires, jointly with any other indemnifying party similarly noticed, to assume control of the defense
thereof with counsel mutually satisfactory to the indemnifying party and the Indemnified Person or the Indemnified Party, as the
case may be; provided, however, that an Indemnified Person or Indemnified Party shall have the right to retain its own counsel with
the fees and expenses of not more than one (1) counsel for such Indemnified Person or Indemnified Party to be paid by the
indemnifying party, if, in the reasonable opinion of counsel retained by the indemnifying party, the representation by such counsel
of the Indemnified Person or Indemnified Party and the indemnifying party would be inappropriate due to actual or potential
differing interests between such Indemnified Person or Indemnified Party and any other party represented by such counsel in such
proceeding. The Indemnified Party or Indemnified Person shall cooperate fully with the indemnifying party in connection with any
negotiation or defense of any such action or claim by the indemnifying party and shall furnish to the indemnifying party all
information reasonably available to the Indemnified Party or Indemnified Person which relates to such action or claim. The
indemnifying party shall keep the Indemnified Party or Indemnified Person fully apprised at all times as to the status of the
defense or any settlement negotiations with respect thereto. No indemnifying party shall be liable for any settlement of any action,
claim or proceeding effected without its prior written consent; provided, however, that the indemnifying party shall not
unreasonably withhold, delay or condition its consent. No indemnifying party shall, without the prior written consent of the
Indemnified Party or Indemnified Person, consent to entry of any judgment or enter into any settlement or other compromise which
does not include as an unconditional term thereof the giving by the claimant or plaintiff to such Indemnified Party or Indemnified
Person of a release from all liability in respect to such claim or litigation. Following indemnification as provided for hereunder,
the indemnifying party shall be subrogated to all rights of the Indemnified Party or Indemnified Person with respect to all third
parties, firms or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice
to the indemnifying party within a reasonable time of the commencement of any such action shall not relieve such indemnifying party
of any liability to the Indemnified Person or Indemnified Party under this Section 6, except to the extent that the indemnifying
party is prejudiced in its ability to defend such action.

 

(d)              
The indemnity agreements contained herein shall be in addition to (i) any cause of action or similar right of the Indemnified
Party or Indemnified Person against the indemnifying party or others, and (ii) any liabilities the indemnifying party may be subject to
pursuant to the law.

 

    10

     

    

 

7.             CONTRIBUTION.

 

To the extent any indemnification
by an indemnifying party is prohibited or limited by law, the indemnifying party agrees to make the maximum contribution with respect
to any amounts for which it would otherwise be liable under Section 6 to the fullest extent permitted by law.

 

8.             REPORTS
UNDER THE EXCHANGE ACT.

 

With a view to making available
to the Investor the benefits of Rule 144 promulgated under the Securities Act or any similar rule or regulation of the SEC that may at
any time permit the Investor to sell securities of the Company to the public without registration, and as a material inducement to the
Investor’s purchase of the Convertible Debentures, the Company represents, warrants, and covenants to the following:

 

(a)              
The Company is subject to the reporting requirements of section 13 or 15(d) of the Exchange Act and has filed all required reports
under section 13 or 15(d) of the Exchange Act during the 12 months prior to the date hereof (or for such shorter period that the issuer
was required to file such reports), other than Form 6-K reports.

 

(b)              
During the Registration Period, the Company shall use its best efforts to file with the SEC in a timely manner all required reports
under section 13 or 15(d) of the Exchange Act (it being understood that nothing herein shall limit the Company’s obligations under
the Securities Purchase Agreement) and such reports shall conform to the requirement of the Exchange Act and the SEC for filing thereunder.

 

(c)              
 The Company shall furnish to the Investor so long as the Investor owns Registrable Securities, promptly upon request, (i) a written
statement by the Company that it has complied with the reporting requirements of Rule 144, (ii) a copy of the most recent annual or interim
report of the Company and such other reports and documents so filed by the Company, which copies may be in electronic form, and (iii)
such other information as may be reasonably requested to permit the Investor to sell such securities pursuant to Rule 144 without registration.

 

    11

     

    

 

9.             AMENDMENT
OF REGISTRATION RIGHTS.

 

Provisions of this Agreement
may be amended and the observance thereof may be waived (either generally or in a particular instance and either retroactively or prospectively),
only with the written consent of the Company and the Investor. Any amendment or waiver effected in accordance with this Section 9
shall be binding upon the Investor and the Company.

 

10.           MISCELLANEOUS.

 

(a)              
Any notices, consents, waivers or other communications required or permitted to be given under the terms of this Agreement must
be in writing and will be deemed to have been delivered pursuant to the notice provisions of the Securities Purchase Agreement or to such
other address and/or electronic mail address and/or to the attention of such other person as the recipient party has specified by written
notice given to each other party five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by
the recipient of such notice, consent, waiver or other communication, (B) electronically generated by the sender’s email service
provider containing the time, date, and recipient email or (C) provided by a courier or overnight courier service shall be rebuttable
evidence of personal service, receipt by facsimile or receipt from a nationally recognized overnight delivery service in accordance with
this section.

 

(b)              
Failure of any party to exercise any right or remedy under this Agreement or otherwise, or delay by a party in exercising such
right or remedy, shall not operate as a waiver thereof.

 

(c)               The
laws of the State of New York shall govern all issues concerning the relative rights of the Company and the Investors as its
stockholders. All other questions concerning the construction, validity, enforcement and interpretation of this Agreement shall be
governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of law provision or
rule (whether of the State of New York or any other jurisdiction) that would cause the application of the laws of any jurisdiction
other than the State of New York. Each party hereby irrevocably submits to the non-exclusive jurisdiction of the Supreme Court of
the State of New York, sitting in New York County, New York and federal courts for the Southern District of New York sitting New
York, New York, for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby
or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is
not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient
forum or that the venue of such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of
process and consents to process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the
address for such notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of
process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner
permitted by law. If any provision of this Agreement shall be invalid or unenforceable in any jurisdiction, such invalidity or
unenforceability shall not affect the validity or enforceability of the remainder of this Agreement in that jurisdiction or the
validity or enforceability of any provision of this Agreement in any other jurisdiction. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY
RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH
OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

    12

     

    

 

(d)              
This Agreement shall inure to the benefit of and be binding upon the permitted successors and assigns of each of the parties hereto.

 

(e)              
The headings in this Agreement are for convenience of reference only and shall not limit or otherwise affect the meaning hereof.

 

(f)               
This Agreement may be executed in identical counterparts, both which shall be considered one and the same agreement and shall become
effective when counterparts have been signed by each party and delivered to the other party. Facsimile or other electronically scanned
and delivered signatures (including any electronic signature covered by the U.S. federal ESIGN Act of 2000, Uniform Electronic Transactions
Act, the Electronic Signatures and Records Act or other applicable law, e.g., www.docusign.com), including by e-mail attachment, shall
be deemed to have been duly and validly delivered and be valid and effective for all purposes of this Agreement.

 

(g)              
Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall execute and deliver
all such other agreements, certificates, instruments and documents, as the other party may reasonably request in order to carry out the
intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated hereby.

 

(h)              
The language used in this Agreement will be deemed to be the language chosen by the parties to express their mutual intent and
no rules of strict construction will be applied against any party.

 

(i)                
This Agreement is intended for the benefit of the parties hereto and their respective permitted successors and assigns, and is
not for the benefit of, nor may any provision hereof be enforced by, any other Person.

 

[REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]

 

    13

     

    

 

IN WITNESS WHEREOF,
the Investor and the Company have caused their signature page to this Registration Rights Agreement to be duly executed as of the date
first above written.

 

	 	
    COMPANY:

	 	SONO GROUP, N.V.

 

		By:	 

	 	Name:
	 	Title:

 

	 	By:	 

	 	Name:
	 	Title:

	 	By:	 

 

	 	
    INVESTOR:

	 	YA II PN, Ltd.

 

		By:	Yorkville Advisors Global, LP
	 	Its:	Investment Manager

 

		By:	Yorkville Advisors Global II, LLC
	 	Its:	General Partner

 

	 	By:	 

	 	Name:
	 	Title:

 

    14Exhibit 10.1

 

SECURITIES PURCHASE AGREEMENT

 

THIS SECURITIES PURCHASE
AGREEMENT (this “Agreement”), dated as of December 7, 2022, is between SONO GROUP N.V., a Dutch
public limited liability company (the “Company”), and YA II PN, LTD. (the “Buyer”).

 

WITNESSETH

 

WHEREAS, the Company
and the Buyer desire to enter into this transaction for the Company to sell and the Buyer to purchase the Convertible Debentures (as defined
below) pursuant to an exemption from registration pursuant to Section 4(a)(2) and/or Rule 506 of Regulation D (“Regulation
D”) as promulgated by the U.S. Securities and Exchange Commission (the “SEC”) under the Securities Act of
1933, as amended (the “Securities Act”);

 

WHEREAS, the parties
desire that, upon the terms and subject to the conditions contained herein, the Company shall issue and sell to the Buyer, as provided
herein, and the Buyer shall purchase convertible debentures in the form attached hereto as “Exhibit A” (the “Convertible
Debentures”) in the aggregate principal amount of $31,100,000, which shall be convertible into ordinary shares of the Company,
nominal value of €0.06 per share (the “Ordinary Shares”) (as converted, the “Conversion Shares”),
of which a Convertible Debenture in the aggregate principal amount of $11,100,000 shall be purchased upon the signing this Agreement (the
 “First Closing”), a Convertible Debenture in the aggregate principal amount of $10,000,000 shall be purchased upon
the filing of a registration statement with the SEC (the “Registration Statement”) registering the resale of the Conversion
Shares by the Buyer (the “Second Closing”), and a Convertible Debenture in the aggregate principal amount $10,000,000
shall be purchased on or about the date the Registration Statement has first been declared effective by the SEC (the “Third Closing”)
(each of the First Closing, Second Closing and Third Closing individually referred to as a “Closing” and collectively
referred to as the “Closings”), in each case at a purchase price equal to 100% of the principal amount of such Convertible
Debenture (the “Purchase Price”) as set forth on the Schedule of Buyer attached as Schedule I to this Agreement (“Schedule
of Buyer”);

 

WHEREAS, contemporaneously
with the execution and delivery of this Agreement, the parties hereto are executing and delivering a Registration Rights Agreement (the
 “Registration Rights Agreement”) pursuant to which the Company has agreed to provide certain registration rights under
the Securities Act and the rules and regulations promulgated thereunder, and applicable state securities laws; and

 

WHEREAS, the Convertible
Debentures and the Conversion Shares are collectively referred to herein as the “Securities.”

 

     

     

    

 

AGREEMENT

 

NOW, THEREFORE, in
consideration of the premises and the mutual covenants contained herein and for other good and valuable consideration, the receipt and
sufficiency of which are hereby acknowledged, the Company and the Buyer hereby agree as follows:

 

	1.	PURCHASE AND SALE OF CONVERTIBLE DEBENTURES.

 

(a)                  
Purchase of Convertible Debentures. Subject to the satisfaction (or waiver) of the conditions set forth in Sections 6 and
7 below, the Company shall issue and sell to the Buyer, and the Buyer agrees to purchase from the Company at each Closing Convertible
Debentures with a principal amount corresponding to the applicable Purchase Price set forth on the Schedule of Buyer attached as Schedule
I hereto.

 

(b)                 
Closing Dates. Each Closing shall occur at the offices Yorkville Advisors Global, LP, 1012 Springfield Avenue, Mountainside,
NJ 07092. The date and time of each Closing shall be as follows: (i) the First Closing shall be at 10:00 a.m., New York time, on the
first Business Day on which the conditions to the First Closing set forth in Sections 6 and 7 below are satisfied or waived (or such
other date as is mutually agreed to by the Company and the Buyer) (the “First Closing Date”), (ii) the Second Closing
shall be at 10:00 a.m., New York time, on the date on which the Registration Statement is filed by the Company with the SEC as set forth
in the Registration Rights Agreement or the first Business Day thereafter, provided the conditions to the Second Closing set forth in
Sections 6 and 7 below are satisfied or waived (or such other date as is mutually agreed to by the Company and the Buyer) (the “Second
Closing Date”), and (iii) the Third Closing shall be at 10:00 a.m., New York time, on the first Business Day after the Registration
Statement is first declared effective by the SEC, provided the conditions to the Third Closing set forth in Sections 6 and 7 below are
satisfied or waived (or such other date as is mutually agreed to by the Company and the Buyer) (the “Third Closing Date”
and, together with the First Closing Date and the Second Closing Date, collectively referred to as the “Closing Dates”).
As used herein “Business Day” means any day other than a Saturday, Sunday or other day on which commercial banks in
New York, New York are authorized or required by law to remain closed.

 

(c)                  
Form of Payment; Deliveries. Subject to the satisfaction of the terms and conditions of this Agreement, on each Closing
Date, (i) the Buyer shall deliver to the Company the Purchase Price for the Convertible Debentures to be issued and sold to Buyer at
such Closing, minus any fees or expenses to be paid directly from the proceeds of such Closing as set forth herein, and (ii) the
Company shall deliver to the Buyer the Convertible Debentures, duly executed on behalf of the Company, with an aggregate principal amount
corresponding to the applicable Purchase Price set forth opposite the Buyer’s name on the Schedule of Buyer attached as Schedule
I hereto.

 

    2

     

    

 

(d)                  Commitment
Fee. The Company shall pay to the Buyer a commitment fee (the “Commitment Fee”) equal to $1,088,500. The
Commitment Fee shall be deducted from the Purchase Price payable by the Buyer in the First Closing and shall thus be deemed to have
been paid to the Buyer at the First Closing.

 

(e)                  
Home Country Practice. Prior to the date hereof, the Company has taken all actions required pursuant to Nasdaq Rule 5615(a)(3)
to duly and validly rely on the exemption for foreign private issuers from applicable rules and regulations of the Nasdaq by adopting
the home country practice (the “Home Country Practice”) in connection with the transactions contemplated hereunder
(including an exemption from any Nasdaq rules that would otherwise require seeking shareholder approval in respect of such transactions).
The Company may issue the relevant Conversion Shares upon conversion of any outstanding Convertible Debentures without regard to the limitations
imposed by Nasdaq Rule 5635(d). So long as any Convertible Debentures are outstanding, the Company shall comply with the Home Country
Practice rules and shall not take any action to change its Home Country Practice or become subject to Nasdaq Rule 5635(d). The Company
will exert reasonable best efforts to maintain the listing and trading of its Ordinary Shares on The Nasdaq Global Market (the “Principal
Market”) and shall comply in all respects with the Company’s reporting, filing and other obligations under the bylaws
or rules of the Principal Market. The Company’s practices in connection with the transactions contemplated hereunder are not prohibited
by its home country’s laws.

 

	2.	BUYER’S REPRESENTATIONS AND WARRANTIES.

 

The Buyer hereby represents
and warrants to the Company that, as of the date hereof and as of each Closing Date:

 

(a)              
Investment Purpose. The Buyer is acquiring the Securities for its own account for investment purposes and not with a view
towards, or for resale in connection with, the public sale or distribution thereof, except pursuant to sales registered under or exempt
from the registration requirements of the Securities Act; provided, however, that by making the representations herein, the Buyer does
not agree, or make any representation or warranty, to hold any of the Securities for any minimum or other specific term and reserves the
right to dispose of the Securities at any time in accordance with, or pursuant to, a registration statement covering such Securities or
an available exemption under the Securities Act. The Buyer does not presently have any agreement or understanding, directly or indirectly,
with any Person to distribute any of the Securities. “Person” means an individual, corporation, limited liability company,
association, partnership, limited partnership, syndicate, person (including, without limitation, a “person” as defined in
Section 13(d)(3) of the Exchange Act), trust, association, or other entity and any Governmental Entity (as defined below).

 

(b)                 
Accredited Investor Status. The Buyer is an institutional “Accredited Investor” as that term is defined in
Rule 501(a)(3) of Regulation D.

 

(c)                  
Reliance on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance on specific
exemptions from the registration requirements of United States federal and state securities laws and that the Company is relying in part
upon the truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the Buyer
to acquire the Securities pursuant to applicable United States securities laws.

 

    3

     

    

 

(d)                 
Information. The Buyer and its advisors (and its counsel), if any, have been furnished with all materials relating to the
business, finances and operations of the Company and information the Buyer deemed material to making an informed investment decision
regarding its purchase of the Securities, which have been requested by the Buyer. The Buyer and its advisors, if any, have been afforded
the opportunity to ask questions of the Company and its management. Neither such inquiries nor any other due diligence investigations
conducted by the Buyer or its advisors, if any, or its representatives shall modify, amend or affect the Buyer’s right to rely
on the Company’s representations and warranties contained in Section 3 below. The Buyer understands that its investment in the
Securities involves a high degree of risk. The Buyer has sought such accounting, legal and tax advice, as it has considered necessary
to make an informed investment decision with respect to its acquisition of the Securities.

 

(e)                  
Transfer or Resale. The Buyer understands that: (i) the Securities have not been registered under the Securities Act or
any state securities laws, and may not be offered for sale, sold, assigned or transferred unless (A) subsequently registered thereunder,
(B) the Buyer shall have delivered to the Company an opinion of counsel, in a generally acceptable form, to the effect that such Securities
to be sold, assigned or transferred may be sold, assigned or transferred pursuant to an exemption from such registration requirements,
or (C) the Buyer provides the Company with reasonable assurances (in the form of seller and broker representation letters) and a legal
opinion under Section 2(e)(i)(B) that such Securities can be sold, assigned or transferred pursuant to Rule 144 promulgated under the
Securities Act, as amended (or a successor rule thereto) (collectively, “Rule 144”), in each case following the applicable
holding period set forth therein; and (ii) any sale of the Securities made in reliance on Rule 144 may be made only in accordance with
the terms of Rule 144 and further, if Rule 144 is not applicable, any resale of the Securities under circumstances in which the seller (or
the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the Securities Act) may require
compliance with some other exemption under the Securities Act or the rules and regulations of the SEC thereunder.

 

(f)                   
Legends. The Buyer agrees to the imprinting, so long as it is required by this Section 2(f), of a restrictive legend on
the Securities in substantially the following form:

 

THE SECURITIES FOR WHICH THIS
CERTIFICATE HAS BEEN ISSUED AND THOSE SECURITIES INTO WHICH THEY ARE CONVERTIBLE HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT
OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES AND THOSE SECURITIES INTO WHICH THEY ARE CONVERTIBLE HAVE
BEEN ACQUIRED SOLELY FOR INVESTMENT PURPOSES AND NOT WITH A VIEW TOWARD RESALE AND MAY NOT BE OFFERED FOR SALE, SOLD, TRANSFERRED OR
ASSIGNED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR
APPLICABLE STATE SECURITIES LAWS, OR AN OPINION OF COUNSEL, IN A GENERALLY ACCEPTABLE FORM, THAT REGISTRATION IS NOT REQUIRED UNDER
SAID ACT OR APPLICABLE STATE SECURITIES LAWS

 

    4

     

    

 

Certificates for the Conversion Shares shall not
contain any legend (including the legend set forth above), (i) while a registration statement covering the resale of such Conversion Shares
is effective under the Securities Act, (ii) following any sale of such Conversion Shares pursuant to Rule 144, (iii) if such Conversion
Shares are eligible for sale under Rule 144, or (iv) if such legend is not required under applicable requirements of the Securities Act
(including judicial interpretations and pronouncements issued by the staff of the SEC). The Buyer agrees that the removal of restrictive
legend from certificates for Securities as set forth in this Section 3(f) is predicated upon the Company’s reliance that the Buyer
will sell any Securities pursuant to either the registration requirements of the Securities Act, including any applicable prospectus delivery
requirements, or an exemption therefrom, and that if Securities are sold pursuant to a registration statement, they will be sold in compliance
with the plan of distribution set forth therein.

 

(g)                 Organization;
Authority. The Buyer is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its
organization with the requisite power and authority to enter into and to consummate the transactions contemplated by the Transaction
Documents (as defined below) to which it is a party and otherwise to carry out its obligations hereunder and thereunder.

 

(h)                 
Authorization, Enforcement. This Agreement has been duly and validly authorized, executed and delivered on behalf of the
Buyer and shall constitute the legal, valid and binding obligations of the Buyer enforceable against the Buyer in accordance with its
terms, except as such enforceability may be limited by general principles of equity or to applicable bankruptcy, insolvency, reorganization,
moratorium, liquidation and other similar laws relating to, or affecting generally, the enforcement of applicable creditors' rights and
remedies.

 

(i)                   
No Conflicts. The execution, delivery and performance by the Buyer of this Agreement and the consummation by the Buyer
of the transactions contemplated hereby will not (i) result in a violation of the organizational documents of the Buyer, (ii) conflict
with, or constitute a default (or an event which with notice or lapse of time or both would become a default) under, or give to others
any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or instrument to which the Buyer is a
party or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state securities
laws) applicable to the Buyer, except, in the case of clauses (ii) and (iii) above, for such conflicts, defaults, rights or violations
which could not, individually or in the aggregate, reasonably be expected to have a material adverse effect on the ability of the Buyer
to perform its obligations hereunder.

 

(j)               
 Certain Trading Activities. The Buyer has not directly or indirectly, nor has any Person acting on behalf of or pursuant
to any understanding with the Buyer, engaged in any transactions in the securities of the Company (including, without limitation, any
Short Sales (as defined below) involving the Company's securities) during the period commencing as of the time that the Buyer first contacted
the Company or the Company's agents regarding the specific investment in the Company contemplated by this Agreement and ending immediately
prior to the execution of this Agreement by the Buyer.

 

    5

     

    

 

	3.	REPRESENTATIONS AND WARRANTIES OF THE COMPANY.

 

The Company hereby makes the
representations and warranties set forth below to the Buyer:

 

(a)            
Organization and Qualification. The Company and each of its Subsidiaries are entities duly formed, validly existing and,
except as disclosed in the SEC Documents, as defined in Section 3(j) below, in good standing (to the extent good standing is a known
concept in the applicable jurisdiction) under the laws of the jurisdiction in which they are formed, and have the requisite power and
authority to own their properties and to carry on their business as now being conducted and as presently proposed to be conducted. The
Company and each of its Subsidiaries is duly qualified as a foreign entity to do business and is in good standing (to the extent good
standing is a known concept in the applicable jurisdiction) in every jurisdiction in which its ownership of property or the nature of
the business conducted by it makes such qualification necessary, except to the extent that the failure to be so qualified or be in good
standing would not reasonably be expected to have a Material Adverse Effect (as defined below). As used in this Agreement, “Material
Adverse Effect” means any material adverse effect on (i) the business, properties, assets, liabilities, operations (including
results thereof) or condition (financial or otherwise) of the Company and its Subsidiaries, taken as a whole, (ii) the transactions contemplated
hereby or in any of the other Transaction Documents or any other agreements or instruments to be entered into by the Company in connection
herewith or therewith or (iii) the authority or ability of the Company to perform any of its obligations under any of the Transaction
Documents (as defined below). “Subsidiaries” means any Person in which the Company, directly or indirectly, owns a
majority of the outstanding capital stock having voting power or holds a majority of the equity or similar interest of such Person, and
each of the foregoing, is individually referred to herein as a “Subsidiary.”

 

(b)            
Authorization; Enforcement; Validity. The Company has the requisite power and authority to enter into and perform
its obligations under this Agreement and the other Transaction Documents and to issue the Securities in accordance with the terms hereof
and thereof. The execution and delivery of this Agreement and the other Transaction Documents by the Company and the consummation by
the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Convertible Debentures
and the reservation for issuance and issuance of the Conversion Shares issuable upon conversion of the Convertible Debentures), have
been duly authorized by the Company's management board and supervisory board and no further filing, consent or authorization is required
by the Company, its management board or its supervisory board or its general meeting of shareholders or any Governmental Entity (as defined
below). This Agreement has been, and the other Transaction Documents to which the Company is a party will be prior to the Closing, duly
executed and delivered by the Company, and each constitutes the legal, valid and binding obligations of the Company, enforceable against
the Company in accordance with its respective terms, except as such enforceability may be limited by general principles of equity or
applicable bankruptcy, insolvency, reorganization, moratorium, liquidation or similar laws relating to, or affecting generally, the enforcement
of applicable creditors' rights and remedies and except as rights to indemnification and to contribution may be limited by federal or
state securities law. “Transaction Documents” means, collectively, this Agreement, the
Registration Rights Agreement, the Convertible Debentures, and each of the other agreements and instruments entered into by the Company
or delivered by the Company in connection with the transactions contemplated hereby and thereby, as may be amended from time to time.

 

    6

     

    

 

(c)            
Issuance of Securities. The issuance of the Securities has been duly authorized and, upon issuance and payment in accordance
with the terms of the Transaction Documents the Securities shall be validly issued, fully paid and non-assessable (meaning
that the holders of the Securities will not by reason of merely being such a holder, be subject to assessment or calls by the Company
or its creditors for further payment on such Securities) and free from all preemptive or similar rights,
mortgages, defects, claims, liens, pledges, charges, taxes, rights of first refusal, encumbrances, security interests and other encumbrances
(collectively “Liens”) with respect to the issuance thereof. As of each Closing Date, the number of Ordinary Shares
comprised in the Company's authorized share capital but unissued and not otherwise reserved for issuance (including (i) in relation to
equity or debt securities convertible into or exchangeable or exercisable for or that can be settled in Ordinary Shares (other than the
Convertible Debentures) and (ii) Ordinary Shares remaining available for issuance under the Company's equity incentive plans) shall be
not less than the maximum number of Ordinary Shares issuable upon conversion of all the Convertible Debentures then outstanding (assuming
for purposes hereof that (x) the Convertible Debentures are convertible at the Floor Price (as defined in the Convertible Debentures)
as of the date of determination, and (y) any such conversion shall not take into account any limitations on the conversion of Convertible
Debentures set forth therein) (the “Required Reserve Amount”). Upon issuance in accordance with conversion of the
Convertible Debentures in accordance with their terms, the Conversion Shares, when issued, will be validly issued, fully paid and nonassessable
(meaning that the holders of the Conversion Shares will not by reason of merely being such a holder, be subject to assessment or calls
by the Company or its creditors for further payment on such Conversion Shares) and free from all preemptive or similar rights or Liens
with respect to the issue thereof, with the holders being entitled to all rights accorded to a holder of Ordinary Shares.

 

(d)            
No Conflicts. The execution, delivery and performance of the Transaction Documents by the Company and the consummation
by the Company of the transactions contemplated hereby and thereby (including, without limitation, the issuance of the Convertible Debentures,
the Conversion Shares, and the reservation for issuance of the Conversion Shares from the Company’s authorized share capital) will
not (i) result in a violation of the Company’s articles of association, or other organizational documents of the Company or any
of its Subsidiaries, or any capital stock or other securities of the Company or any of its Subsidiaries, (ii) conflict with, or constitute
a default under, or give to others any rights of termination, amendment, acceleration or cancellation of, any agreement, indenture or
instrument to which the Company or any of its Subsidiaries is a party, or (iii) result in a violation of any law, rule, regulation, order,
judgment or decree (including, without limitation, U.S. federal and state securities laws and regulations, the securities laws of the
jurisdictions of the Company's incorporation or in which it or its subsidiaries operate and the rules and regulations of Principal
Market and including all applicable laws, rules and regulations of the country of incorporation of the Company) applicable to the Company
or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries is bound or affected, except in
the case of (ii) and (iii) for any conflict, default, right or violation that would not reasonably be expected to result in a Material
Adverse Effect. 

 

    7

     

    

 

(e)            
Consents. The Company is not required to obtain any material consent from, authorization or order of, or make any filing
or registration with (other than any filings as may be required by any federal or state securities agencies and any filings as may be
required by the Principal Market), any Governmental Entity (as defined below) or any regulatory or self-regulatory agency or any other
Person in order for it to execute, deliver or perform any of its obligations under or contemplated by the Transaction Documents, in each
case, in accordance with the terms hereof or thereof. All consents, authorizations, orders, filings and registrations which the Company
or any Subsidiary is required to obtain pursuant to the preceding sentence have been or will be obtained or effected on or prior to each
Closing Date, and neither the Company nor any of its Subsidiaries are aware of any facts or circumstances which might prevent the Company
or any of its Subsidiaries from obtaining or effecting any of the registration, application or filings contemplated by the Transaction
Documents. The Company is not in violation of the requirements of the Principal Market and has no knowledge of any facts or circumstances
which could reasonably lead to delisting or suspension of the Ordinary Shares in the foreseeable future. The Company has notified the
Principal Market of the issuance of all of the Securities hereunder, which does not require obtaining the approval of the stockholders
of the Company or any other Person or Governmental Entity, and the Principal Market has completed its review of the related Listing of
Additional Share form. “Governmental Entity” means any nation, state, county, city, town, village, district, or other political
jurisdiction of any nature, federal, state, local, municipal, foreign, or other government, governmental or quasi-governmental authority
of any nature (including any governmental agency, branch, department, official, or entity and any court or other tribunal), multi-national
organization or body; or body exercising, or entitled to exercise, any administrative, executive, judicial, legislative, police,
regulatory, or taxing authority or power of any nature or instrumentality of any of the foregoing, including any entity or enterprise
owned or controlled by a government or a public international organization or any of the foregoing.

 

(f)              Acknowledgment
Regarding Buyer's Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely in the capacity of
an arm's length purchaser with respect to the Transaction Documents and the transactions contemplated hereby and thereby and that
the Buyer is not (i) an officer or director of the Company or any of its Subsidiaries, (ii) to its knowledge, an
 "affiliate" (as defined in Rule 144) of the Company or any of its Subsidiaries or (iii) to its knowledge, a
 “beneficial owner” of more than 10% of the shares of Ordinary Shares (as defined for purposes of Rule 13d-3 of the 1934
Act). The Company further acknowledges that neither the Buyer (nor any affiliate of the Buyer) is acting as a financial advisor or
fiduciary of the Company or any of its Subsidiaries (or in any similar capacity) with respect to the Transaction Documents and the
transactions contemplated hereby and thereby, and any advice given by the Buyer or any of its representatives or agents in
connection with the Transaction Documents and the transactions contemplated hereby and thereby is merely incidental to the Buyer's
purchase of the Securities. The Company further represents to the Buyer that the Company's decision to enter into the Transaction
Documents to which it is a party has been based solely on the independent evaluation by the Company and its representatives.

 

    8

     

    

 

(g)            No
Integrated Offering. None of the Company, its Subsidiaries or any of their affiliates, nor any Person acting on their behalf has,
directly or indirectly, made any offers or sales of any security or solicited any offers to buy any security, under circumstances that
would cause this offering of the Securities to require approval of stockholders of the Company under any applicable stockholder approval
provisions, including, without limitation, under the rules and regulations of any exchange or automated quotation system on which any
of the securities of the Company are listed or designated for quotation. None of the Company, its Subsidiaries, their affiliates nor
any Person acting on their behalf will take any action or steps that would cause the offering of any of the Securities to be integrated
with other offerings of securities of the Company.

 

(h)            Dilutive
Effect. The Company understands and acknowledges that the number of Conversion Shares will increase in certain circumstances. The
Company further acknowledges its obligation to issue the Conversion Shares upon conversion of the Convertible Debentures in accordance
with the terms thereof is absolute and unconditional, regardless of the dilutive effect that such issuance may have on the ownership
interests of other stockholders of the Company.

 

(i)             
SEC Documents; Financial Statements. Since its initial public offering in November 2021, the Company has timely filed
all reports and other documents required to be filed by it with the SEC pursuant to the reporting requirements of the Exchange Act (all
of the foregoing filed prior to the date hereof and all exhibits and appendices included therein and financial statements, notes and
schedules thereto and documents incorporated by reference therein being hereinafter referred to as the “SEC Documents”).
The Company has delivered or has made available to the Buyer or their respective representatives true, correct and complete copies of
each of the SEC Documents not available on the EDGAR system. To the best of the Company’s knowledge, as of their respective dates,
the SEC Documents complied in all material respects with the requirements of the Exchange Act and the rules and regulations of the SEC
promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they were filed with the SEC, contained
any untrue statement of a material fact or omitted to state a material fact required to be stated therein or necessary in order to make
the statements therein, in the light of the circumstances under which they were made, not misleading. To the best of the Company’s
knowledge, as of their respective dates, the financial statements of the Company included in the SEC Documents complied in all material
respects with applicable accounting requirements and the published rules and regulations of the SEC with respect thereto as in effect
as of the time of filing. Such financial statements have been prepared in accordance with International Financial Reporting Standards
(“IFRS”) as issued by the International Accounting Standards Board, consistently applied, during the periods involved (except,
if applicable, (i) as may be otherwise indicated in such financial statements or the notes thereto, or (ii) in the case of unaudited
interim statements, to the extent they may exclude footnotes or may be condensed or summary statements) and fairly present in all material
respects the financial position of the Company as of the dates thereof and the results of its operations and cash flows for the periods
then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments which will not be material, either individually
or in the aggregate). The reserves, if any, established by the Company or the lack of reserves, if applicable, are reasonable based upon
facts and circumstances known by the Company on the date hereof and there are no loss contingencies that are required to be accrued by
the Statement of Financial Accounting Standard No. 5 of the Financial Accounting Standards Board which are not provided for by the Company
in its financial statements or otherwise. No other information provided by or on behalf of the Company to the Buyer which is not included
in the SEC Documents contains any untrue statement of a material fact or omits to state any material fact necessary in order to make
the statements therein not misleading, in the light of the circumstance under which they are or were made. The Company is not currently
contemplating to amend or restate any of the financial statements (including, without limitation, any notes or any letter of the independent
accountants of the Company with respect thereto) included in the SEC Documents (the “Financial
Statements”), nor is the Company currently aware of facts or circumstances which would require the Company to amend or restate
any of the Financial Statements, in each case, in order for any of the Financials Statements to be in compliance with IFRS and the rules
and regulations of the SEC. The Company has not been informed by its independent accountants that they recommend that the Company amend
or restate any of the Financial Statements or that there is any need for the Company to amend or restate any of the Financial Statements.

 

    9

     

    

 

(j)             Absence
of Certain Changes. Since the date of the Company's most recent audited financial statements contained in its Form 20-F, and except
as disclosed in the SEC documents that have been filed after the date of such Form 20-F, there has been no Material Adverse Effect, nor
any event or occurrence specifically affecting the Company or its Subsidiaries that would be reasonably expected to result in a Material
Adverse Effect. Since the date of the Company's most recent audited financial statements contained in its Form 20-F, neither the Company
nor any of its Subsidiaries has (i) declared or paid any dividends, (ii) sold any material assets, individually or in the aggregate,
outside of the ordinary course of business or (iii) made any material capital expenditures, individually or in the aggregate, outside
of the ordinary course of business. Neither the Company nor any of its Subsidiaries has taken any steps to seek protection pursuant to
any law or statute relating to bankruptcy, insolvency, reorganization, receivership, liquidation or winding up, nor does the Company
or any Subsidiary have any knowledge or reason to believe that any of their respective creditors intend to initiate involuntary bankruptcy
proceedings or any actual knowledge of any fact which would reasonably lead a creditor to do so.

 

(k)            
No Undisclosed Events, Liabilities, Developments or Circumstances. No event, liability, development or circumstance has
occurred or exists, or is reasonably expected to exist or occur specific to the Company, any of its Subsidiaries or any of their respective
businesses, properties, liabilities, prospects, operations (including results thereof) or condition (financial or otherwise), that has
not been publicly disclosed and would reasonably be expected to have a Material Adverse Effect.

 

(l)             Conduct
of Business; Regulatory Permits. Except as disclosed in the SEC Documents, neither the Company nor any of its Subsidiaries is
in violation of any term under its Articles of Association, any certificate of designation, preferences or rights of any other outstanding
series of preferred stock of the Company or any of its Subsidiaries or their organizational charter, certificate of formation, memorandum
of association, Articles of Association or certificate of incorporation or, respectively, which would reasonably be expected to have
a Material Adverse Effect. Except as disclosed in the SEC Documents, neither the Company nor any of its Subsidiaries is in violation
of any judgment, decree or order or any statute, ordinance, rule or regulation applicable to the Company or any of its Subsidiaries,
and neither the Company nor any of its Subsidiaries will conduct its business in violation of any of the foregoing, except in all cases
for violations which would not reasonably be expected to have a Material Adverse Effect. Without limiting the generality of the foregoing,
the Company is not in violation of any of the rules, regulations or requirements of the Principal Market and has no knowledge of any
facts or circumstances that could reasonably lead to delisting or suspension of the Ordinary Shares by the Principal Market in the foreseeable
future. During the one year prior to the date hereof, (i) the Ordinary Shares have been listed or designated for quotation on the Principal
Market, (ii) trading in the Ordinary Shares has not been suspended by the SEC or the Principal Market and (iii) the Company has received
no communication, written or oral, from the SEC or the Principal Market regarding the suspension or delisting of the Ordinary Shares
from the Principal Market, which has not been publicly disclosed. The Company and each of its Subsidiaries possess all certificates,
authorizations and permits issued by the appropriate regulatory authorities necessary to conduct their respective businesses, except
where the failure to possess such certificates, authorizations or permits would not reasonably be expected to have, individually or in
the aggregate, a Material Adverse Effect, and neither the Company nor any of its Subsidiaries has received any notice of proceedings
relating to the revocation or modification of any such certificate, authorization or permit. There is no agreement, commitment, judgment,
injunction, order or decree binding upon the Company or any of its Subsidiaries or to which the Company or any of its Subsidiaries is
a party which has or would reasonably be expected to have the effect of prohibiting or materially impairing any business practice of
the Company or any of its Subsidiaries, any acquisition of property by the Company or any of its Subsidiaries or the conduct of business
by the Company or any of its Subsidiaries as currently conducted other than such effects, individually or in the aggregate, which have
not had and would not reasonably be expected to have a Material Adverse Effect on the Company or any of its Subsidiaries.

 

    10

     

    

 

(m)         
Foreign Corrupt Practices. Neither the Company nor any of its Subsidiaries nor any director, officer, agent, employee,
nor any other person acting for or on behalf of the Company or any of its Subsidiaries (individually and collectively, a “Company
Affiliate”) have violated the U.S. Foreign Corrupt Practices Act or any other applicable anti-bribery or anti-corruption laws,
nor has any Company Affiliate offered, paid, promised to pay, or authorized the payment of any money, or offered, given, promised to
give, or authorized the giving of anything of value, to any officer, employee or any other person acting in an official capacity for
any Governmental Entity to any political party or official thereof or to any candidate for political office (individually and collectively,
a “Government Official”) or to any person under circumstances where such Company Affiliate knew or was aware of a
high probability that all or a portion of such money or thing of value would be offered, given or promised, directly or indirectly, to
any Government Official, for the purpose, in violation of applicable law, of: (i) (A) influencing any act or decision of such Government
Official in his/her official capacity, (B) inducing such Government Official to do or omit to do any act in violation of his/her lawful
duty, (C) securing any improper advantage, or (D) inducing such Government Official to influence or affect any act or decision of any
Governmental Entity, or (ii) assisting the Company or its Subsidiaries in obtaining or retaining business for or with, or directing business
to, the Company or its Subsidiaries.

 

(n)            
Equity Capitalization.

 

(i)                
Definitions:

 

(A)             
“High Voting Shares” means the Company's high voting shares, nominal value of €1.50 per share that form
part of the Company’s authorized and/or issued share capital from time to time, as applicable.

 

(ii)              Authorized
Share Capital. As of the date hereof, the authorized share capital of the Company consists of (A) 320,000,000 Ordinary Shares, of
which, 90,554,115 are issued and outstanding and (B) 4,000,000 High Voting Shares, of which 3,000,000 are issued and outstanding.

 

(iii)            
Valid Issuance; Available Shares. All of such outstanding shares in the Company's capital are duly authorized and
have been validly issued and are fully paid and non-assessable (meaning that the holders of those shares will not by reason of merely
being such a holder, be subject to assessment or calls by the Company or its creditors for further payment on such shares).

 

(iv)             
Existing Securities; Obligations. Except as disclosed in the SEC Documents: (A) none of the Company's or any Subsidiary's
shares, interests or capital stock is subject to preemptive rights or any other similar rights or Liens suffered or permitted by the
Company or any Subsidiary; (B) there are no outstanding options, warrants, scrip, rights to subscribe to, calls or commitments of
any character whatsoever relating to, or securities or rights convertible into, or exercisable or exchangeable for, any shares, interests
or capital stock of the Company or any of its Subsidiaries, or contracts, commitments, understandings or arrangements by which the Company
or any of its Subsidiaries is or may become bound to issue additional shares, interests or capital stock of the Company or any of its
Subsidiaries or options, warrants, scrip, rights to subscribe to, calls or commitments of any character whatsoever relating to, or securities
or rights convertible into, or exercisable or exchangeable for, any shares, interests or capital stock of the Company or any of its Subsidiaries;
(C) there are no agreements or arrangements under which the Company or any of its Subsidiaries is obligated to register the sale of any
of their securities under the Securities Act (except pursuant to this Agreement); (D) there are no outstanding securities or instruments
of the Company or any of its Subsidiaries which contain any redemption or similar provisions, and there are no contracts, commitments,
understandings or arrangements by which the Company or any of its Subsidiaries is or may become bound to redeem a security of the Company
or any of its Subsidiaries; (E) there are no securities or instruments containing anti-dilution or similar provisions that will
be triggered by the issuance of the Securities; and (G) neither the Company nor any Subsidiary has any stock appreciation rights
or "phantom stock" plans or agreements or any similar plan or agreement.

 

(v)               
Organizational Documents. The Company has furnished to the Buyer or filed on EDGAR true, correct and complete copies of
the Company's Articles of Association, as amended and as in effect on the date hereof (the “Articles of Association”).

 

(o)            
Litigation. Except as disclosed in the SEC Documents, there is no action, suit, arbitration, proceeding, inquiry or investigation
before or by the Principal Market, any court, public board, other Governmental Entity, self-regulatory organization or body pending or,
to the knowledge of the Company, threatened against or affecting the Company or any of its Subsidiaries, the Ordinary Shares or any of
the Company's or its Subsidiaries' officers or directors, whether of a civil or criminal nature or otherwise, in their capacities as
such, which would reasonably be expected to result in a Material Adverse Effect. The Company is not aware of any event which might result
in or form the basis for any such action, suit, arbitration, investigation, inquiry or other proceeding. Without limitation of the foregoing,
there has not been, and to the knowledge of the Company, there is not pending or contemplated, any investigation by the SEC involving
the Company, any of its Subsidiaries or any current or former director or officer of the Company or any of its Subsidiaries. Neither
the Company nor any of its Subsidiaries is the subject of any order, writ, judgment, injunction, decree, determination or award of any
Governmental Entity that would reasonably be expected to result in a Material Adverse Effect.

 

(p)            
Manipulation of Price. Neither the Company nor any of its Subsidiaries has, and, to the knowledge of the Company, no Person
acting on their behalf has, directly or indirectly, (i) taken any action designed to cause or to result in the stabilization or manipulation
of the price of any security of the Company or any of its Subsidiaries to facilitate the sale or resale of any of the Securities, (ii)
sold, bid for, purchased, or paid any compensation for soliciting purchases of, any of the Securities, or (iii) paid or agreed to pay
to any Person any compensation for soliciting another to purchase any other securities of the Company or any of its Subsidiaries.

 

    11

     

    

 

(q)            
Registration Eligibility. The Company is eligible to register the resale of the Conversion Shares by the Buyer using either
Form F-1 or Form F-3 promulgated under the Securities Act.

 

(r)             
Shell Company Status. The Company is not, and has never been, an issuer identified in, or subject to, Rule 144(i).

 

(s)            
Sanctions Matters.  Neither the Company nor any of its Subsidiaries or, to the knowledge of the Company, any director,
officer or controlled affiliate of the Company or any director or officer of any Subsidiary, is a Person that is, or is owned or controlled
by a Person that is (i) the subject of any sanctions administered or enforced by the U.S. Department of Treasury’s Office
of Foreign Asset Control (“OFAC”), the United Nations Security Council, the European Union, Her Majesty’s Treasury,
or other relevant sanctions authorities, including, without limitation, designation on OFAC’s Specially Designated Nationals and
Blocked Persons List or OFAC’s Foreign Sanctions Evaders List or other relevant sanctions authority (collectively, “Sanctions”),
or (ii) located, organized or resident in a country or territory that is the subject of Sanctions that broadly prohibit dealings
with that country or territory (including, without limitation, the Crimea region, the Donetsk People’s Republic and Luhansk People’s
Republic in Ukraine, Cuba, Iran, North Korea, Russia, Sudan and Syria “Sanctioned Countries”)). Neither the
Company nor any of its Subsidiaries nor any director, officer or controlled affiliate of the Company or any of its Subsidiaries, has
ever had funds blocked by a United States bank or financial institution, temporarily or otherwise, as a result of OFAC concerns.

 

(t)             
Disclosure. The Company confirms that neither it nor any other Person acting on its behalf has provided the Buyer or its
agents or counsel with any information that constitutes or could reasonably be expected to constitute material, non-public information
concerning the Company or any of its Subsidiaries, other than the existence of the transactions contemplated by this Agreement and the
other Transaction Documents. The Company understands and confirms that the Buyer will rely on the foregoing representations in effecting
transactions in securities of the Company. All disclosures provided to the Buyer regarding the Company and its Subsidiaries, their businesses
and the transactions contemplated hereby, including the schedules to this Agreement, furnished by or on behalf of the Company or any
of its Subsidiaries, taken as a whole, are true and correct in all material respects and do not contain any untrue statement of a material
fact or omit to state any material fact necessary in order to make the statements made therein, in the light of the circumstances under
which they were made, not misleading. All of the written information furnished after the date hereof by or on behalf of the Company or
any of its Subsidiaries to the Buyer pursuant to or in connection with this Agreement and the other Transaction Documents, taken as a
whole, will be true and correct in all material respects as of the date on which such information is so provided and will not contain
any untrue statement of a material fact or omit to state any material fact necessary in order to make the statements made therein, in
the light of the circumstances under which they were made, not misleading. No event or circumstance has occurred or information exists
with respect to the Company or any of its Subsidiaries or its or their business, properties, liabilities, prospects, operations (including
results thereof) or conditions (financial or otherwise), which, under applicable law, rule or regulation, requires public disclosure
at or before the date hereof or announcement by the Company but which has not been so publicly disclosed. All financial projections and
forecasts that have been prepared by or on behalf of the Company or any of its Subsidiaries and made available to the Buyer have been
prepared in good faith based upon reasonable assumptions and represented, at the time each such financial projection or forecast was
delivered to the Buyer, the Company's best estimate of future financial performance (it being recognized that such financial projections
or forecasts are not to be viewed as facts and that the actual results during the period or periods covered by any such financial projections
or forecasts may differ from the projected or forecasted results). The Company acknowledges and agrees that the Buyer does not make or
has not made any representations or warranties with respect to the transactions contemplated hereby other than those specifically set
forth in Section 2.

 

    12

     

    

 

(u)            
No General Solicitation. Neither the Company, nor any of its affiliates, nor any Person acting on its or their behalf,
has engaged in any form of general solicitation or general advertising (within the meaning of Regulation D under the Securities Act)
in connection with the offer or sale of the Securities.

 

(v)            
Private Placement. Assuming the accuracy of the Buyer’s representations and warranties set forth in Section 2, no
registration under the Securities Act is required for the offer and sale of the Securities by the Company to the Buyer as contemplated
hereby. The issuance and sale of the Securities hereunder does not contravene the rules and regulations of the Primary Market.

 

	4.	COVENANTS.

 

(a)            
Reporting Status. For the period beginning on the date hereof, and ending 6 months after the date on which all the Convertible
Debentures are no longer outstanding (the “Reporting Period”), the Company shall use its best efforts file on a timely
basis all reports required to be filed with the SEC pursuant to the Exchange Act, and the Company shall not terminate its status as an
issuer required to file reports under the Exchange Act even if the Exchange Act or the rules and regulations thereunder would no longer
require or otherwise permit such termination.

 

(b)             Use
of Proceeds. Neither the Company nor any of its Subsidiaries will, directly or indirectly, use the proceeds of the transactions
contemplated herein to repay any loans to any executives or employees of the Company or to make any payments in respect of any
related party debt. Neither the Company nor any of its Subsidiaries will, directly or indirectly, use the proceeds from the
transactions contemplated herein, or lend, contribute or otherwise make available such proceeds to any subsidiary, joint venture
partner or other Person (a) for the purpose of funding or facilitating any activities or business of or with any Person or in
any country or territory that, at the time of such funding or facilitation, is the subject of Sanctions or is a Sanctioned Country,
or (b) in any other manner that will result in a violation of Sanctions by any Person (including any Person participating in
the transactions contemplated by this Agreement, whether as underwriter, advisor, investor or otherwise). For the past five years,
neither the Company nor any of its Subsidiaries has engaged in, and is not now engaged in, any dealings or transactions with any
Person, or in any country or territory, that at the time of the dealing or transaction is or was the subject of Sanctions or was a
Sanctioned Country.

 

    13

     

    

 

(c)              
Listing. To the extent applicable, the Company shall promptly secure the listing or designation for quotation (as the case
may be) of all of the Underlying Securities (as defined below) upon each national securities exchange and automated quotation system,
if any, upon which the Ordinary Shares are then listed or designated for quotation (as the case may be, each an “Eligible Market”),
subject to official notice of issuance, and shall use reasonable efforts to maintain such listing or designation for quotation (as the
case may be) of all Underlying Securities from time to time issuable under the terms of the Transaction Documents on such Eligible Market
for the Reporting Period. Neither the Company nor any of its Subsidiaries shall take any action which could be reasonably expected to
result in the delisting or suspension of the Ordinary Shares on an Eligible Market during the Reporting Period. The Company shall pay
all fees and expenses in connection with satisfying its obligations under this Section 4(c). “Underlying Securities”
means the (i) the Conversion Shares, and (ii) any Ordinary Shares of the Company issued or issuable with respect to the Conversion Shares,
including, without limitation, (1) as a result of any stock split, stock dividend, recapitalization, exchange or similar event or otherwise
and (2) shares of capital stock of the Company into which the Ordinary Shares are converted or exchanged without regard to any limitations
on conversion of the Convertible Debentures.

 

(d)              
Fees. The Company shall pay to YA Global II SPV, LLC, an affiliate of the Buyer, a one-time due diligence and structuring
fee of $15,000. Any unpaid balance of due diligence and structuring fee shall be deducted from the Purchase Price payable to the Company
at the First Closing.

 

(e)              
Pledge of Securities. Notwithstanding anything to the contrary contained in this Agreement, the Company acknowledges and
agrees that, subject to compliance with applicable federal and state securities laws, the Securities may be pledged by the Buyer in connection
with a bona fide margin agreement or other loan or financing arrangement that is secured by the Securities. The Company hereby agrees
to execute and deliver such documentation as a pledgee of the Securities may reasonably request in connection with a pledge of the Securities
to such pledgee by the Buyer.

 

(f)                Disclosure
of Transactions and Other Material Information. On or before 9:30 a.m., New York time, on the first Business Day after the date
of this Agreement, the Company shall file a current report on Form 6-K describing all the material terms of the transactions
contemplated by the Transaction Documents in the form required by the Exchange Act and attaching all the material Transaction
Documents (including, without limitation, this Agreement (and all schedules to this Agreement) (including all attachments, the
 “Current Report”). From and after the filing of the Current Report, the Company shall have disclosed all
material, non-public information (if any) provided to the Buyer by the Company or any of its Subsidiaries or any of their respective
officers, directors, employees or agents in connection with the transactions contemplated by the Transaction Documents. In addition,
effective upon the filing of the Current Report and/or the Company’s interim report for the nine-month period ended September
30, 2022 on Form 6-K, whichever is later, the Company acknowledges and agrees that any and all confidentiality or similar
obligations with respect to the transactions contemplated by the Transaction Documents under any agreement, whether written or oral,
between the Company, any of its Subsidiaries or any of their respective officers, directors, affiliates, employees or agents, on the
one hand, and the Buyer or any of its affiliates, on the other hand, including without limitation the confidentiality provisions set
forth in the Non-Binding Term Sheet dated as of November 21, 2022, shall terminate. The Company shall not, and the Company shall
cause each of its Subsidiaries and each of its and their respective officers, directors, employees and agents not to, provide the
Buyer with any material, non-public information regarding the Company or any of its Subsidiaries from and after the date hereof
without first obtaining the express prior written consent of the Buyer (which may be granted or withheld in the Buyer's sole
discretion).

 

    14

     

    

 

(g)              
Reservation of Shares. So long as any of the Convertible Debentures remain outstanding, the Company shall take all action
necessary to at all times have a number of Ordinary Shares comprised in the Company's authorized share capital but unissued and not otherwise
reserved for issuance (including (i) in relation to equity or debt securities convertible into or exchangeable or exercisable for or that
can be settled in Ordinary Shares (other than the Convertible Debentures) and (ii) Ordinary Shares remaining available for issuance under
the Company's equity incentive plans) that is no less than the Required Reserve Amount; provided that at no time shall the number of Ordinary
Shares reserved pursuant to this Section 4(g) be reduced other than proportionally with respect to all Ordinary Shares in connection with
any conversion (other than pursuant to the conversion of the Convertible Debentures in accordance with their terms) and/or cancellation,
or reverse stock split. If at any time the number of Ordinary Shares reserved pursuant to this Section 4(g) becomes less than the Required
Reserve Amount, the Company will promptly take all corporate action necessary to propose to its general meeting of shareholders an increase
of its authorized share capital necessary to meet the Company's obligations pursuant to the Transaction Documents, recommending that shareholders
vote in favor of such increase.

 

(h)              
Conduct of Business. During the Reporting Period, the business of the Company and its Subsidiaries shall not be conducted
in violation of any law, ordinance or regulation of any Governmental Entity, except where such violations would not reasonably be expected
to result, either individually or in the aggregate, in a Material Adverse Effect.

 

(i)               
Short Selling. The Buyer hereby agrees that it shall not directly or indirectly, engage in any Short Sales involving the
Company’s securities during the period commencing on the date hereof and ending when no Convertible Debentures remain outstanding.
 "Short Sales" means all "short sales" as defined in Rule 200 promulgated under Regulation SHO under the Exchange Act.

 

    15

     

    

 

(j)                Trading Information. Upon the Company’s request, the Buyer agrees to provide the Company with trading reports setting
forth the number and average sales prices of Ordinary Shares sold by the Buyer in the prior trading week along with the total aggregate
number of Ordinary Shares traded on each Trading Day. “Trading Day” means a day on which the Ordinary Shares are quoted or
traded on an Eligible Market on which the Ordinary Shares are then quoted or listed; provided, that in the event that the Ordinary Shares
are not listed or quoted, then Trading Day shall mean a Business Day.

 

(k)               Certain
Issuances and Charter Amendments. From the date hereof until all the Convertible Debentures have been repaid, unless the Buyer shall
have given prior written consent, the Company shall not, and shall not permit any of its subsidiaries (whether or not a subsidiary on
the date hereof) to, directly or indirectly (i) amend its charter documents, including, without
limitation, its Articles of Association, in any manner that materially and adversely affects any rights of the holders of the Convertible
Debentures, (ii) increase the nominal value of its Ordinary Shares (except in the context of the reverse share split that was proposed
to the Company’s general meeting on December 6, 2022), (iii) make any payments in respect of any related party debt, or (iv) enter
into, agree to enter into, or effect, any Variable Rate Transaction other than with the Buyer. “Variable Rate Transaction”
shall mean a transaction in which the Company (i) issues or sells any equity or debt securities that are convertible into, exchangeable
or exercisable for, or include the right to receive additional shares of Ordinary Shares either (A) at a conversion price, exercise price,
exchange rate or other price that is based upon and/or varies with the trading prices of or quotations for the Ordinary Shares at any
time after the initial issuance of such equity or debt securities, or (B) with a conversion, exercise or exchange price that is subject
to being reset at some future date after the initial issuance of such equity or debt security or upon the occurrence of specified or
contingent events directly or indirectly related to the business of the Company or the market for the Ordinary Shares (including, without
limitation, any “full ratchet” or “weighted average” anti-dilution provisions, but not including any standard
anti-dilution protection for any reorganization, recapitalization, non-cash dividend, stock split or other similar transaction), or (ii)
enters into any agreement, including but not limited to an “equity line of credit,” or other continuous offering or similar
offering of Ordinary Shares; provided that this provision shall not apply to the Company’s existing committed equity facility
entered into between the Company and Joh. Berenberg, Gossler & Co. KG (“Berenberg”) pursuant to the purchase agreement
dated June 12, 2022 between the Company and Berenberg (the “Berenberg Agreement”) or an agreement for an “at-the-market”
or other continuous offering of Ordinary Shares (an “ATM Agreement”) with one or more U.S. registered broker-dealers
(whereby the Company may sell Ordinary shares at prices determined in the future, but subject to the Two Percent Cap (as defined below));
provided further that the Company shall only have either the Berenberg Agreement or a single ATM Agreement in place at any time. Upon
a written request by the Investor, the Company shall provide the Investor with trading statements and other information confirming its
compliance with the restrictions set forth herein.

 

    16

     

    

 

With
respect to the Berenberg Agreement, or any existing or future ATM Agreement, so long as any amounts are outstanding under the Convertible
Debentures, the Company hereby undertakes that, unless otherwise waived with the Buyer’s prior written consent (which may be given
or withheld at the Buyer’s sole discretion), it will limit the use of the Berenberg Agreement or such ATM Agreement to no more than
two percent (2%) (the “Two Percent Cap”) of the daily trading volume of the Company’s Ordinary Shares on the
Principal Market. Notwithstanding the foregoing, if the trading volume of the Company’s Ordinary Shares (as measured by multiplying
the volume of Ordinary Shares traded on the Principal Market by the Volume Weighted Average Price of such Ordinary Shares) on a trading
day is:

 

		(a)	between $5.0 million and $10.0 million, then the Two Percent
Cap shall be increased from two percent (2%) to ten percent (10%) on such trading day; and

 

		(b)	greater than $10.0 million, then the Two Percent Cap shall be
increased from two percent (2%) to fifteen percent (15%) on such trading day.

 

	5.	REGISTER; LEGEND.

 

(a)              
Register. The Company shall maintain at its principal executive offices or with the transfer agent and registrar of the
Company (or at such other office or agency of the Company as it may designate by notice to the Buyer), a register for the Convertible
Debentures in which the Company shall record the name and address of the Person in whose name the Convertible Debentures have been issued
(including the name and address of each transferee), the amount of Convertible Debentures held by such Person. The Company shall keep
the register open and available at all times during business hours for inspection of the Buyer or its legal representatives.

 

(b)              
Transfer Restrictions. The Securities may only be disposed of in compliance with state and federal securities laws. In connection
with any transfer of Securities other than pursuant to an effective registration statement or Rule 144, to the Company or to an Affiliate
of the Buyer or in connection with a pledge as contemplated herein, the Company may require the transferor thereof to provide to the Company
an opinion of counsel selected by the transferor and reasonably acceptable to the Company, the form and substance of which opinion shall
be reasonably satisfactory to the Company, to the effect that such transfer does not require registration of such transferred Securities
under the Securities Act. As a condition of transfer, any such transferee shall agree in writing to be bound by the terms of this Agreement
and shall have the rights and obligations of the Buyer under this Agreement.

 

    17

     

    

 

	6.	CONDITIONS TO THE COMPANY’S OBLIGATION TO SELL.

 

The obligation of the Company
hereunder to issue and sell the Convertible Debentures to the Buyer at each Closing is subject to the satisfaction, at or before each
Closing Date, of each of the following conditions, provided that these conditions are for the Company's sole benefit and may be waived
by the Company at any time in its sole discretion by providing the Buyer with prior written notice thereof:

 

(a)              
The Buyer shall have executed each of the relevant Transaction Documents to which it is a party and delivered the same to the Company.

 

(b)              
The Buyer shall have delivered to the Company the relevant Purchase Price (less, with respect to the First Closing only, the amounts
to be withheld pursuant to Section 1(d) and Section 4(d)) for the Convertible Debentures being purchased by the Buyer at the Closing by
wire transfer of immediately available funds in accordance with the Closing Statement (as defined in Section 7(i) below).

 

(c)              
The representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and
as of each Closing Date as though originally made at that time (except for representations and warranties that speak as of a specific
date, which shall be true and correct as of such specific date), and the Buyer shall have performed, satisfied and complied in all material
respects with the covenants, agreements and conditions required by this Agreement to be performed, satisfied or complied with by the Buyer
at or prior to such Closing Date.

 

	7.	CONDITIONS TO THE BUYER'S OBLIGATION TO PURCHASE.

 

The obligation of the Buyer hereunder to purchase
the Convertible Debentures at each Closing is subject to the satisfaction, at or before each Closing Date, of each of the following conditions,
provided that these conditions are for the Buyer's sole benefit and may be waived by the Buyer at any time in its sole discretion by providing
the Company with prior written notice thereof:

 

(a)              
The Company shall have duly executed and delivered to the Buyer each of the relevant Transaction Documents to which it is a party
and the Company shall have duly executed and delivered to the Buyer (by a member of the Company’s management board serving at the
time of adoption of the authorization of the execution and delivery of this Agreement and the other Transaction Documents) a Convertible
Debenture with the applicable principal amount corresponding to the relevant Purchase Price set forth opposite the Buyer’s name
on Schedule of Buyer attached as Schedule I for the Closing.

 

(b)              
The Buyer shall have received the opinion of counsel to the Company, dated as of the First Closing Date, in the form reasonably
acceptable to the Buyer.

 

(c)              
Each and every representation and warranty of the Company shall be true and correct in all material respects (other than representations
and warranties qualified by materiality, which shall be true and correct in all respects) as of the date when made and as of each Closing
Date as though originally made at that time (except for representations and warranties that speak as of a specific date, which shall be
true and correct as of such specific date) and the Company shall have performed, satisfied and complied in all respects with the covenants,
agreements and conditions required to be performed, satisfied or complied with by the Company at or prior to each Closing Date as set
forth in each Transaction Document.

 

(d)               The
Ordinary Shares (A) shall be designated for quotation or listed (as applicable) on the Principal Market and (B) shall not have been
suspended, as of each Closing Date, by the SEC or the Principal Market from trading on the Principal Market nor shall suspension by
the SEC or the Principal Market have been threatened, as of each Closing Date, either (I) in writing by the SEC or the Principal
Market or (II) by falling below the minimum maintenance requirements of the Principal Market.

 

    18

     

    

 

(e)              
The Company shall have obtained all governmental, regulatory or third-party consents and approvals, if any, necessary for the sale
of the Securities, including without limitation, those required by the Principal Market, if any.

 

(f)               
No statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated or endorsed
by any court or Governmental Entity of competent jurisdiction that prohibits the consummation of any of the transactions contemplated
by the Transaction Documents.

 

(g)              
From the date hereof to the applicable Closing Date, no event or series of events shall have occurred that has resulted in or would
reasonably be expected to result in a Material Adverse Effect

 

(h)              
The Company shall have obtained approval of the Principal Market to list or designate for quotation (as the case may be) the maximum
number of Conversion Shares issuable pursuant to the Convertible Debentures to be issued at the Closing.

 

(i)               
The Buyer shall have received a letter, duly executed by an officer of the Company, setting forth the wire amounts of the Buyer
and the wire transfer instructions of the Company (the “Closing Statement”).

 

(j)               
(i) From the date hereof to the applicable Closing Date, trading in the Ordinary Shares shall not have been suspended by the SEC
or the Principal Market (except for any suspension of trading of limited duration agreed to by the Company, which suspension shall be
terminated prior to the Closing), (ii) the closing price of the Ordinary Shares during each of the five (5) consecutive Trading Days immediately
prior to the applicable Closing Date shall be at least 120% of the Floor Price (as defined in the Convertible Debentures), and (iii) at
any time from the date hereof to the applicable Closing Date, trading in securities generally as reported by Bloomberg L.P. shall not
have been suspended or limited, or minimum prices shall not have been established on securities whose trades are reported by such service,
or on the Principal Market, nor shall a banking moratorium have been declared either by the United States or New York State authorities
nor shall there have occurred any material outbreak or escalation of hostilities or other national or international calamity of such magnitude
in its effect on, or any material adverse change in, any financial market which, in each case, in the reasonable judgment of the Buyer,
makes it impracticable or inadvisable to purchase the Securities at the Closing.

 

(k)              
The Company and its Subsidiaries shall have delivered to the Buyer such other documents, instruments or certificates relating to
the transactions contemplated by this Agreement as the Buyer or its counsel may reasonably request.

 

(l)               
 Solely with respect to the Second Closing, the Company shall have filed the Registration Statement with the SEC in accordance
with the provisions set forth in the Registration Rights Agreement, including the filing deadline set forth therein.

 

(m)             
Solely with respect to the Third Closing, the Registration Statement shall be effective in accordance with the provisions set forth
in the Registration Rights Agreement, including the effectiveness deadline set forth therein.

 

    19

     

    

 

	8.	TERMINATION.

 

In the event
that the First Closing shall not have occurred within five (5) days of the date hereof, then the Buyer shall have the right to terminate
its obligations under this Agreement at any time on or after the close of business on such date without liability of the Buyer to any
other party; provided, however, the right to terminate this Agreement under this Section 8 shall not be available to the Buyer if
the failure of the transactions contemplated by this Agreement to have been consummated by such date is the result of the Buyer's breach
of this Agreement, provided further that no such termination shall affect any obligation of the Company under this Agreement to reimburse
the Buyer for the expenses described herein unless the Buyer shall be deemed to breach this Agreement. Nothing contained in this Section
8 shall be deemed to release any party from any liability for any breach by such party of the terms and provisions of this Agreement or
the other Transaction Documents or to impair the right of any party to compel specific performance by any other party of its obligations
under this Agreement or the other Transaction Documents.

 

	9.	MISCELLANEOUS.

 

(a)              
Recitals. The recitals to this Agreement are a material and substantive part of this Agreement. The recitals are incorporated
herein and made part of this Agreement.

 

(b)              Governing
Law; Jurisdiction; Jury Trial. All questions concerning the construction, validity, enforcement and interpretation of this
Agreement shall be governed by the internal laws of the State of New York, without giving effect to any choice of law or conflict of
law provision or rule (whether of the State of New York or any other jurisdictions) that would cause the application of the laws of
any jurisdictions other than the State of New York. The Company hereby irrevocably submits to the exclusive jurisdiction of the
state and federal courts sitting in The City of New York, Borough of Manhattan, for the adjudication of any dispute hereunder or in
connection herewith or under any of the other Transaction Documents or with any transaction contemplated hereby or thereby, and
hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject
to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of
such suit, action or proceeding is improper. Each party hereby irrevocably waives personal service of process and consents to
process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address for such notices
to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice thereof.
Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. Nothing
contained herein shall be deemed or operate to preclude any Buyer from bringing suit or taking other legal action against the
Company in any other jurisdiction to collect on the Company's obligations to such Buyer or to enforce a judgment or other court
ruling in favor of such Buyer. EACH PARTY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE TO, AND AGREES NOT TO REQUEST, A JURY
TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR UNDER ANY OTHER TRANSACTION DOCUMENT OR IN CONNECTION WITH OR ARISING OUT OF
THIS AGREEMENT, ANY OTHER TRANSACTION DOCUMENT OR ANY TRANSACTION CONTEMPLATED HEREBY OR THEREBY.

 

    20

     

    

 

(c)              
Counterparts. This Agreement may be executed in two or more identical counterparts, all of which shall be considered one
and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other party. In
the event that any signature is delivered by facsimile transmission or by an e-mail which contains a portable document format (.pdf) file
of an executed signature page, such signature page shall create a valid and binding obligation of the party executing (or on whose behalf
such signature is executed) with the same force and effect as if such signature page were an original thereof.

 

(d)              
Electronic Signatures. The words “execution,” “signed,” “signature,” and words of like
import in this Agreement shall be deemed to include electronic signatures or electronic records, each of which shall be of the same legal
effect, validity or enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may
be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National Commerce
Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions
Act.

 

(e)              
Headings; Gender. The headings of this Agreement are for convenience of reference and shall not form part of, or affect
the interpretation of, this Agreement. Unless the context clearly indicates otherwise, each pronoun herein shall be deemed to include
the masculine, feminine, neuter, singular and plural forms thereof. The terms "including," "includes," "include"
and words of like import shall be construed broadly as if followed by the words "without limitation." The terms "herein,"
 "hereunder," "hereof" and words of like import refer to this entire Agreement instead of just the provision in which
they are found.

 

(f)                Entire
Agreement, Amendments. This Agreement supersedes all other prior oral or written agreements between the Buyer, the Company,
their affiliates and persons acting on their behalf with respect to the matters discussed herein (including, without limitation, any
term sheets, including that Non-Binding Convertible Debenture Term Sheet dated as of November 21, 2022)(the “Term
Sheet”), except to the extent that any provisions of that the Term Sheet are binding under their terms and intended to survive
termination of the Term Sheet) and which shall terminate in accordance with the terms set forth in the Term Sheet , and this
Agreement and the instruments referenced herein contain the entire understanding of the parties with respect to the matters covered
herein and therein and, except as specifically set forth herein or therein, neither the Company nor the Buyer makes any
representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement may be waived or
amended other than by an instrument in writing signed by the party to be charged with enforcement.

 

    21

     

    

 

(g)              
Notices. Any notices, consents, waivers or other communications required or permitted to be given under the terms of this
Agreement must be in writing by letter and email and will be deemed to have been delivered: upon the later of (A) either (i) receipt,
when delivered personally or (ii) one (1) Business Day after deposit with an overnight courier service with next day delivery specified,
in each case, properly addressed to the party to receive the same and (B) receipt, when sent by electronic mail. The addresses and e-mail
addresses for such communications shall be:

 

	If to the Company, to:	SONO GROUP N.V.
	 	
    Waldmeisterstraße 76

    80935 Munich

    Germany

    Telephone: +49 (89) 4520 5818 

Attention:  Legal Department

E-Mail:  legal@sonomotors.com

     

	With Copy to:	
    Sullivan & Cromwell LLP

    Neue Mainzer Strasse 52

    60311 Frankfurt am Main

    Germany

    Telephone:  +49 (69) 4272 5200

    Attention:  Clemens Rechberger

    E-Mail:  ###

     

	If to the Buyer, to its address and e-mail address set forth on the Schedule of Buyer, with copies to the Buyer's representatives as set forth on the Schedule of Buyer,
	 	 
	With copy to:	
    David Fine, Esq.

    c/o Yorkville Advisors Global, LP

    1012 Springfield Avenue

    Mountainside, NJ 07092

    Email: legal@yorkvilleadvisors.com

 

or to such other address, e-mail
address and/or to the attention of such other Person as the recipient party has specified by written notice given to each other party
five (5) days prior to the effectiveness of such change. Written confirmation of receipt (A) given by the recipient of such notice, consent,
waiver or other communication, (B) electronically generated by the sender's e-mail service provider containing the time, date, recipient
e-mail address or (C) provided by an overnight courier service shall be rebuttable evidence of personal service, receipt by facsimile
or receipt from an overnight courier service in accordance with clause (i), (ii) or (iii) above, respectively.

 

    22

     

    

 

(h)              
Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their respective
successors and assigns, including any purchasers of any of the Convertible Debentures (but excluding any purchasers of Underlying Securities,
unless pursuant to a written assignment by the Buyer). The Company shall not assign this Agreement or any rights or obligations hereunder
without the prior written consent of the Buyer. In connection with any transfer of any or all of its Securities, the Buyer may assign
all, or a portion, of its rights and obligations hereunder in connection with such Securities without the consent of the Company, in which
event such assignee shall be deemed to be the Buyer hereunder with respect to such transferred Securities.

 

(i)               
Indemnification.

 

(i)                
In consideration of the Buyer's execution and delivery of the Transaction Documents and acquiring the Securities thereunder and
in addition to all of the Company's other obligations under the Transaction Documents, the Company shall defend, protect, indemnify and
hold harmless the Buyer its stockholders, partners, members, officers, directors, employees and agents (collectively, the “Indemnitees”)
from and against any and all actions, causes of action, suits, claims, losses, costs, penalties, fees, liabilities and damages, and expenses
in connection therewith, and including reasonable attorneys' fees and disbursements (the “Indemnified Liabilities”),
incurred by any Indemnitee as a result of, or arising out of, or relating to (i) any misrepresentation or breach of any representation
or warranty made by the Company in any of the Transaction Documents, (ii) any breach of any covenant, agreement or obligation of the Company
or any Subsidiary contained in any of the Transaction Documents or (iii) any cause of action, suit, proceeding or claim brought or made
against such Indemnitee by a third party (including for these purposes a derivative action brought on behalf of the Company or any Subsidiary)
or which otherwise involves such Indemnitee that arises out of or results from (A) the execution, delivery, performance or enforcement
of any of the Transaction Documents, (B) , or (C) the status of the Buyer or holder of the Securities either as an investor in the Company
pursuant to the transactions contemplated by the Transaction Documents or as a party to this Agreement (including, without limitation,
as a party in interest or otherwise in any action or proceeding for injunctive or other equitable relief). The Company will not be liable
to any Indemnitee under the foregoing indemnification provisions, for any settlement by an Indemnitee effected without the Company’s
prior written consent (except as set forth below), or (b) to the extent that any Indemnified Liability of such Indemnitee is finally determined
by a court or arbitral tribunal to have resulted from the willful misconduct or gross negligence of the Buyer or any other Indemnitee,
and any expenses incurred in connection therewith that were previously reimbursed to the Buyer or any other Indemnitee by the Company
will be repaid to the Company by the Buyer and such other Indemnitee. To the extent that the foregoing undertaking by the Company may
be unenforceable for any reason, the Company shall make the maximum contribution to the payment and satisfaction of each of the Indemnified
Liabilities which is permissible under applicable law.

 

(ii)              Promptly
after receipt by an Indemnitee under this Section 9(i) of notice of the commencement of any action or proceeding (including any
governmental action or proceeding) involving an Indemnified Liability, such Indemnitee shall, if a claim in respect thereof is to be
made against the Company under this Section 9(i), deliver to the Company a written notice of the commencement thereof, and the
Company shall have the right to participate in, and, to the extent the Company so desires, to assume control of the defense thereof
with counsel mutually reasonably satisfactory to the Company and the Indemnitee; provided, however, that an Indemnitee shall
have the right to retain its own counsel with the fees and expenses of such counsel to be paid by the Company if: (A) the Company
has agreed in writing to pay such fees and expenses; (B) the Company shall have failed promptly to assume the defense of such
Indemnified Liability and to employ counsel reasonably satisfactory to such Indemnitee in any such Indemnified Liability; or
(C) the named parties to any such Indemnified Liability (including any impleaded parties) include both such Indemnitee and the
Company, and such Indemnitee shall have been advised by counsel that a conflict of interest is likely to exist if the same counsel
were to represent such Indemnitee and the Company (in which case, if such Indemnitee notifies the Company in writing that it elects
to employ separate counsel at the expense of the Company, then the Company shall not have the right to assume the defense thereof
and such counsel shall be at the expense of the Company), provided further, that in the case of clause (C) above the Company shall
not be responsible for the reasonable fees and expenses of more than one (1) separate legal counsel for the Indemnitees. The
Indemnitee shall reasonably cooperate with the Company in connection with any negotiation or defense of any such action or
Indemnified Liability by the Company and shall furnish to the Company all information reasonably available to the Indemnitee which
relates to such action or Indemnified Liability. The Company shall keep the Indemnitee reasonably apprised at all times as to the
status of the defense or any settlement negotiations with respect thereto. The Company shall not be liable for any settlement of any
action, claim or proceeding effected without its prior written consent, provided, however, that the Company shall not unreasonably
withhold, delay or condition its consent. The Company shall not, without the prior written consent of the Indemnitee, consent to
entry of any judgment or enter into any settlement or other compromise which does not include as an unconditional term thereof the
giving by the claimant or plaintiff to such Indemnitee of a release from all liability in respect to such Indemnified Liability or
litigation, and such settlement shall not include any admission as to fault on the part of the Indemnitee. Following indemnification
as provided for hereunder, the Company shall be subrogated to all rights of the Indemnitee with respect to all third parties, firms
or corporations relating to the matter for which indemnification has been made. The failure to deliver written notice to the Company
within a reasonable time of the commencement of any such action shall not relieve the Company of any liability to the Indemnitee
under this Section 9(i), except to the extent that the Company is materially and adversely prejudiced in its ability to defend such
action.

 

    23

     

    

 

(iii)           
The indemnification required by this Section 9(i) shall be made by periodic payments of the amount thereof during the course of
the investigation or defense, within ten (10) days after bills supporting the Indemnified Liabilities are received by the Company.

 

(iv)            
The indemnity agreement contained herein shall be in addition to (A) any cause of action or similar right of the Indemnitee against
the Company or others, and (B) any liabilities the Company may be subject to pursuant to the law.

 

(j)               
 No Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to
express their mutual intent, and no rules of strict construction will be applied against any party.

 

[REMAINDER PAGE
INTENTIONALLY LEFT BLANK]

 

    24

     

    

 

IN WITNESS WHEREOF,
the Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed as of
the date first written above.

 

	 	
    COMPANY: 

	 	 
	 	SONO GROUP N.V.

 

		By:	 

	 	Name:
	 	Title:

 

	 	By:	 

	 	Name:
	 	Title:

 

    25

     

    

 

IN WITNESS WHEREOF,
the Buyer and the Company have caused their respective signature page to this Securities Purchase Agreement to be duly executed as of
the date first written above.

 

	 	
    BUYER:

	 	 
	 	YA II PN, LTD. 

 

		By:	Yorkville Advisors Global, LP
	 	Its:	Investment Manager

 

		By:	Yorkville Advisors Global II, LLC
	 	Its:	General Partner

 

	 	By:	 

	 	Name:
	 	Title:

 

    26

     

    

 

LIST OF EXHIBITS:

 

    27

     

    

 

EXHIBIT A

 

FORM OF CONVERTIBLE DEBENTURES

 

    28

     

    

 

SCHEDULE I

SCHEDULE OF BUYER

 

	(a)	 	 	 	(c)	 
	Buyer	 	 	 	Purchase Price

 for Convertible

 Debentures	 
	YA II PN, Ltd.	 	 	 	 	 	 
	1012 Springfield Avenue	 	First Closing:	 	$	11,100,000.00	 
	Mountainside, NJ 07092	 	Second Closing	 	$	10,000,000.00	 
	Email: Legal@yorkvilleadvisors.com	 	Third Closing	 	$	10,000,000.00	 
	 	 	Total:	 	$	31,100,000.00	 

 

The Commitment Fee in
the amount of $1,088,500 shall be deducted from the proceeds of the First Closing.

 

Legal Representative’s Address and E-Mail Address

David Fine, Esq.

1012 Springfield Avenue

Mountainside, NJ 07092

Email: Legal@yorkvilleadvisors.com

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00351-of-00352.parquet"}]]